<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>eb7bcef887a877066e2c932dee6d95a6-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft10{font-size:11px;font-family:Times;color:#231f20;}
	.ft11{font-size:12px;font-family:Times;color:#231f20;}
	.ft12{font-size:12px;font-family:Times;color:#231f20;}
	.ft13{font-size:17px;font-family:Times;color:#261e5a;}
	.ft14{font-size:9px;font-family:Times;color:#261e5a;}
	.ft15{font-size:9px;font-family:Times;color:#231f20;}
	.ft16{font-size:9px;font-family:Times;color:#231f20;}
	.ft17{font-size:34px;font-family:Times;color:#231f20;}
	.ft18{font-size:13px;font-family:Times;color:#231f20;}
	.ft19{font-size:8px;font-family:Times;color:#231f20;}
	.ft110{font-size:11px;font-family:Times;color:#231f20;}
	.ft111{font-size:11px;font-family:Times;color:#231f20;}
	.ft112{font-size:5px;font-family:Times;color:#231f20;}
	.ft113{font-size:19px;font-family:Times;color:#261e5a;-moz-transform: matrix(         0,         -1,          1,          0, 0, 0);-webkit-transform: matrix(         0,         -1,          1,          0, 0, 0);-o-transform: matrix(         0,         -1,          1,          0, 0, 0);-ms-transform: matrix(         0,         -1,          1,          0, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft114{font-size:11px;line-height:16px;font-family:Times;color:#231f20;}
	.ft115{font-size:12px;line-height:17px;font-family:Times;color:#231f20;}
	.ft116{font-size:34px;line-height:38px;font-family:Times;color:#231f20;}
	.ft117{font-size:11px;line-height:17px;font-family:Times;color:#231f20;}
	.ft118{font-size:11px;line-height:18px;font-family:Times;color:#231f20;}
	.ft119{font-size:9px;line-height:15px;font-family:Times;color:#231f20;}
	.ft120{font-size:9px;line-height:13px;font-family:Times;color:#231f20;}
	.ft121{font-size:9px;line-height:11px;font-family:Times;color:#231f20;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page1-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:509px;left:64px;white-space:nowrap" class="ft115"><b>INTRODUCTION<br/></b>The replacement of cells that are lost to normal physiological<br/>turnover relies, in part, on mechanisms that control stem cell<br/>number and the efficient, functional integration of their progeny<br/>into&#160;differentiated tissues.&#160;Examples&#160;of such tissue homeostasis are<br/>provided by the mammalian hematopoietic and digestive systems,<br/>in which millions of differentiated blood and epithelial cells expire<br/>daily, only to be replaced by the fresh division progeny of resident<br/>stem cells (Clarke and Fuller,&#160;2006; Reya&#160;and Clevers,&#160;2005).<br/>Failure in these processes can lead to a range of dysfunctions,<br/>including malignant transformation.</p>
<p style="position:absolute;top:696px;left:79px;white-space:nowrap" class="ft11">One of the most frequently mutated genes in human cancers is</p>
<p style="position:absolute;top:713px;left:64px;white-space:nowrap" class="ft115">the gene encoding the phosphatase and tensin homolog deleted<br/>on chromosome 10 (PTEN) protein (Sansal and Sellers, 2004; Stiles<br/>et al., 2004; Sulis and Parsons, 2003). PTEN negatively regulates<br/>the phosphatidylinositol-3 kinase (PI3K)-AKT signaling, known to<br/>play&#160;crucial roles in cellular proliferation, differentiation and<br/>migration in both vertebrates and invertebrates (Sulis and Parsons,<br/>2003). In mammals,&#160;when PTEN&#160;activity is lost in organs displaying<br/>high rates of cell turnover, primary and metastatic cancers are<br/>detected. Germline mutations of PTEN are found in both Cowden<br/>and Bannayan-Riley-Ruvalcaba syndromes (Liaw et al., 1997; Marsh<br/>et al., 1997; Marsh et al., 1999; Nelen et al., 1997), and somatic<br/>mutations have been associated with&#160;Non-Hodgkin’s&#160;lymphoma<br/>(Nakahara et al., 1998), breast, and prostate cancers (Li et al., 1997).</p>
<p style="position:absolute;top:508px;left:468px;white-space:nowrap" class="ft115">More&#160;recently, activation of PI3K and AKT owing to PTEN loss of<br/>function has been reported to occur not only in breast, but also in<br/>some types of pancreatic, cancers (Asano et al., 2004; Kirkegaard<br/>et al., 2005). Thus, a rapidly growing body of evidence suggests a<br/>central role for PTEN&#160;in the regulation and misregulation of tissue<br/>homeostasis in mammals (Marx, 2007).</p>
<p style="position:absolute;top:610px;left:483px;white-space:nowrap" class="ft11">In invertebrates such as&#160;<i>Drosophila melanogaster&#160;</i>and</p>
<p style="position:absolute;top:627px;left:468px;white-space:nowrap" class="ft12"><i>Caenorhabditis elegans</i></p>
<p style="position:absolute;top:627px;left:606px;white-space:nowrap" class="ft11">, PTEN appears to mainly control cell size</p>
<p style="position:absolute;top:644px;left:468px;white-space:nowrap" class="ft115">and cell cycle during development (Hafen, 2004; Stiles et al., 2004).<br/>In&#160;<i>C.&#160;elegans</i>, PTEN (<i>daf-18</i>) has been associated&#160;with&#160;regulation<br/>of metabolic rates, longevity and dauer formation (Gil et al., 1999;<br/>Mihaylova et al., 1999; Ogg and Ruvkun, 1998). In Drosophila,<br/>PTEN plays critical roles during development,&#160;affecting cell<br/>proliferation, and cell and organ size (Gao et al., 2000; Goberdhan<br/>et al., 1999; Huang et al., 1999; Oldham et al., 2002). Although<br/>studies of PTEN in invertebrates have been highly informative,<br/>the study of PTEN in adult tissue homeostasis remains unexplored.<br/>As such, models are not yet available to dissect the mechanisms<br/>by which human diseases involving PTEN mutations are<br/>manifested.</p>
<p style="position:absolute;top:848px;left:483px;white-space:nowrap" class="ft11">In contrast to flies and nematodes, the adult freshwater planarian</p>
<p style="position:absolute;top:866px;left:468px;white-space:nowrap" class="ft12"><i>Schmidtea mediterranea</i></p>
<p style="position:absolute;top:865px;left:623px;white-space:nowrap" class="ft11">possesses an abundant&#160;population of</p>
<p style="position:absolute;top:882px;left:468px;white-space:nowrap" class="ft115">undifferentiated cells, many of which are continuously undergoing<br/>cell division. The dividing,&#160;undifferentiated cells are known as<br/>neoblasts, and the animal derives its robust tissue homeostasis and<br/>regenerative properties from both regulating the proliferation of<br/>these cells and by determining their division progeny (Newmark<br/>and Sánchez Alvarado, 2000). Neoblasts are considered the adult<br/>stem cells in planarians because they&#160;constantly self-renew&#160;and<br/>produce daughter cells that&#160;will go on to&#160;differentiate&#160;into&#160;all known<br/>cell types found in the animal, including the germline (Newmark<br/>and Sánchez Alvarado, 2002). In fact, neoblasts are the only known<br/>proliferative cell in the flatworm, and their division progeny is<br/>instrumental in supporting, and maintaining, differentiated tissues</p>
<p style="position:absolute;top:28px;left:678px;white-space:nowrap" class="ft13"><b>RESEARCH ARTICLE</b></p>
<p style="position:absolute;top:1100px;left:64px;white-space:nowrap" class="ft14"><b>Disease Models &amp; Mechanisms</b></p>
<p style="position:absolute;top:1100px;left:836px;white-space:nowrap" class="ft15"><b>131</b></p>
<p style="position:absolute;top:35px;left:64px;white-space:nowrap" class="ft14"><b>Disease Models &amp; Mechanisms&#160;</b>1, 131-143 (2008)&#160;doi:10.1242/dmm.000117</p>
<p style="position:absolute;top:100px;left:64px;white-space:nowrap" class="ft116">Planarian PTEN homologs regulate stem cells and<br/>regeneration through TOR signaling</p>
<p style="position:absolute;top:193px;left:64px;white-space:nowrap" class="ft18">Néstor J. Oviedo1,*, Bret J. Pearson2, Michael Levin1&#160;and Alejandro Sánchez Alvarado2,*</p>
<p style="position:absolute;top:236px;left:64px;white-space:nowrap" class="ft10"><b>SUMMARY</b></p>
<p style="position:absolute;top:259px;left:64px;white-space:nowrap" class="ft118">We have identified two genes,&#160;<i>Smed-PTEN-1&#160;</i>and&#160;<i>Smed-PTEN</i>-<i>2</i>, capable of regulating stem cell function in the planarian&#160;<i>Schmidtea mediterranea</i>.<br/>Both genes encode proteins homologous to the mammalian tumor suppressor, phosphatase and tensin homolog deleted on chromosome 10 (PTEN).<br/>Inactivation of&#160;<i>Smed-PTEN-1&#160;</i>and -<i>2&#160;</i>by RNA interference (RNAi) in planarians disrupts regeneration, and leads to abnormal outgrowths in both cut<br/>and uncut animals followed soon after by death (lysis). The resulting phenotype&#160;is characterized by hyperproliferation of neoblasts (planarian stem<br/>cells), tissue disorganization and a significant accumulation of postmitotic cells with impaired differentiation capacity. Further analyses revealed that<br/>rapamycin selectively prevented such accumulation without affecting the normal neoblast proliferation associated with physiological turnover and<br/>regeneration. In animals in which PTEN function is abrogated, we also detected a significant increase in the number of cells expressing the planarian<br/><i>Akt&#160;</i>gene homolog (<i>Smed-Akt</i>). However, functional abrogation of&#160;<i>Smed-Akt&#160;</i>in&#160;<i>Smed-PTEN&#160;</i>RNAi-treated animals does not prevent cell overproliferation<br/>and lethality, indicating that functional abrogation of&#160;<i>Smed-PTEN&#160;</i>is sufficient to induce abnormal outgrowths. Altogether, our data reveal roles for<br/>PTEN in the regulation of planarian stem cells that are strikingly conserved to mammalian models. In addition, our results implicate this protein in<br/>the control of stem cell maintenance during the regeneration of complex structures in planarians.</p>
<p style="position:absolute;top:991px;left:64px;white-space:nowrap" class="ft120">1Center for Regenerative and Developmental Biology, Forsyth Institute, and<br/>Developmental Biology Department, Harvard School of Dental Medicine, Boston,<br/>MA 02115, USA<br/>2Department of Neurobiology and Anatomy, Howard Hughes Medical Institute,<br/>School of Medicine, University of Utah, Salt Lake City, UT 84132, USA<br/>*Authors for correspondence (e-mail: noviedo@drmichaellevin.org;<br/>sanchez@neuro.utah.edu)</p>
<p style="position:absolute;top:728px;left:45px;white-space:nowrap" class="ft113"><i>D</i></p>
<p style="position:absolute;top:715px;left:45px;white-space:nowrap" class="ft113"><i>isease Models &amp; Mechanisms &#160; &#160; &#160; &#160;&#160;</i></p>
<p style="position:absolute;top:466px;left:45px;white-space:nowrap" class="ft113"><i>DMM</i></p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>eb7bcef887a877066e2c932dee6d95a6-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft20{font-size:12px;font-family:Times;color:#231f20;}
	.ft21{font-size:12px;font-family:Times;color:#231f20;}
	.ft22{font-size:11px;font-family:Times;color:#231f20;}
	.ft23{font-size:11px;font-family:Times;color:#231f20;}
	.ft24{font-size:9px;font-family:Times;color:#261e5a;}
	.ft25{font-size:9px;font-family:Times;color:#231f20;}
	.ft26{font-size:9px;font-family:Times;color:#231f20;}
	.ft27{font-size:17px;font-family:Times;color:#261e5a;}
	.ft28{font-size:10px;font-family:Times;color:#231f20;}
	.ft29{font-size:10px;font-family:Times;color:#231f20;}
	.ft210{font-size:10px;font-family:Times;color:#231f20;}
	.ft211{font-size:10px;font-family:Times;color:#231f20;}
	.ft212{font-size:19px;font-family:Times;color:#261e5a;-moz-transform: matrix(         0,         -1,          1,          0, 0, 0);-webkit-transform: matrix(         0,         -1,          1,          0, 0, 0);-o-transform: matrix(         0,         -1,          1,          0, 0, 0);-ms-transform: matrix(         0,         -1,          1,          0, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft213{font-size:12px;line-height:17px;font-family:Times;color:#231f20;}
	.ft214{font-size:12px;line-height:17px;font-family:Times;color:#231f20;}
	.ft215{font-size:11px;line-height:17px;font-family:Times;color:#231f20;}
	.ft216{font-size:11px;line-height:16px;font-family:Times;color:#231f20;}
	.ft217{font-size:10px;line-height:15px;font-family:Times;color:#231f20;}
	.ft218{font-size:10px;line-height:15px;font-family:Times;color:#231f20;}
	.ft219{font-size:10px;line-height:15px;font-family:Times;color:#231f20;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page2-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:100px;left:64px;white-space:nowrap" class="ft213">during physiological cell turnover (Reddien and Sánchez Alvarado,<br/>2004; Sánchez Alvarado, 2006). After amputation, planarians<br/>develop a specialized structure at the cut surface, known as a<br/>regeneration blastema, which is the result of extensive proliferation<br/>by neoblasts.</p>
<p style="position:absolute;top:185px;left:79px;white-space:nowrap" class="ft20">Here, we report the identification of two&#160;<i>PTEN&#160;</i>orthologs in</p>
<p style="position:absolute;top:202px;left:64px;white-space:nowrap" class="ft213">planarians (<i>Smed-PTEN-1&#160;</i>and&#160;<i>Smed-PTEN-2</i>). RNA interference<br/>(RNAi) of these genes is lethal; the phenotype is characterized<br/>by an inhibition of tissue regeneration, abnormal outgrowths<br/>associated with&#160;a neoblast-hyperproliferative response, and a lack<br/>of cell differentiation and tissue maintenance. Strikingly, we also<br/>observed that the abnormalities and lethality detected in worms<br/>with&#160;RNAi&#160;of&#160;both&#160;<i>Smed-PTEN&#160;</i>genes [<i>Smed-PTEN</i>-<i>1, -2(RNAi)<br/></i>worms] could be prevented by pharmacological treatment with<br/>rapamycin (an inhibitor of the protein kinase, target of rapamycin<br/>[TOR]), without affecting physiological neoblast proliferation.<br/>Because specific upregulation of the planarian&#160;<i>Akt-like&#160;</i>gene<br/>(<i>Smed-Akt</i>) is detected in RNAi-treated animals and prevented<br/>by rapamycin treatment, it is likely that an involvement of the<br/>AKT&#160;pathway&#160;is&#160;necessary&#160;for&#160;the&#160;<i>Smed-PTEN&#160;</i>genes to exert<br/>their function. Together, these observations support recent<br/>evidence demonstrating that PTEN activity can help distinguish<br/>differences between normal and abnormal self-renewing<br/>mechanisms in stem cells during malignant transformation in<br/>mammals (Yilmaz et al., 2006; Zhang et al., 2006). We propose<br/>that, in planarians, PTEN&#160;modulates AKT function and that&#160;the<br/>abnormalities observed in the&#160;<i>Smed-PTEN&#160;</i>phenotype are due</p>
<p style="position:absolute;top:100px;left:468px;white-space:nowrap" class="ft213">to both autonomous and non-autonomous stem cell roles of<br/>PTEN. Additionally, our data revealed&#160;that&#160;AKT is required for<br/>rapamycin to compensate for PTEN loss of function. Thus, we<br/>propose that planarians may serve as a powerful model system<br/>in which to dissect the roles of tumor suppressor activities in<br/>regulating stem cell functions.</p>
<p style="position:absolute;top:220px;left:468px;white-space:nowrap" class="ft213"><b>RESULTS<br/>Three PTEN homologs exist in&#160;<i>S. mediterranea<br/></i></b>All known PTEN homologs share conserved phosphatase and<br/>tensin domains (Lee et al., 1999). Initially, we identified potential<br/>homologs by performing BLAST searches against the planarian<br/>genome with both the fly and human&#160;<i>PTEN&#160;</i>genes. We then took<br/>the predicted planarian sequences, which contained both of the<br/>conserved domains, and carried out reciprocal BLAST searches<br/>against the human and fly genomes. This returned a list of three<br/>potential orthologs of PTEN.&#160;</p>
<p style="position:absolute;top:390px;left:483px;white-space:nowrap" class="ft20">In addition to&#160;<i>PTEN</i>, humans possess two other&#160;<i>PTEN</i>-like genes</p>
<p style="position:absolute;top:407px;left:468px;white-space:nowrap" class="ft213">that contain phosphatase and tensin domains,&#160;<i>TPIP&#160;</i>and&#160;<i>TPTE&#160;</i>(Sulis<br/>and Parsons, 2003). To clearly define the orthology between planarian<br/><i>PTEN</i></p>
<p style="position:absolute;top:441px;left:503px;white-space:nowrap" class="ft20">-like genes and the other human homologs, phylogenetic</p>
<p style="position:absolute;top:458px;left:468px;white-space:nowrap" class="ft213">analyses were carried out (see Methods). The results indicate that<br/>planaria have two paralogous bona fide&#160;<i>PTEN&#160;</i>orthologs and a gene<br/>orthologous to&#160;the human&#160;<i>TPTE&#160;</i>and&#160;<i>TPIP&#160;</i>genes (Fig. 1A). cDNAs<br/>for both&#160;<i>PTEN&#160;</i>genes had been previously cloned as part of a cDNA<br/>sequencing project (Sánchez Alvarado et al., 2002). We will refer to<br/>these genes as&#160;<i>Smed-PTEN-1&#160;</i>and&#160;<i>Smed-PTEN-2.</i></p>
<p style="position:absolute;top:1100px;left:756px;white-space:nowrap" class="ft24"><b>dmm.biologists.org</b></p>
<p style="position:absolute;top:1100px;left:64px;white-space:nowrap" class="ft25"><b>132</b></p>
<p style="position:absolute;top:35px;left:670px;white-space:nowrap" class="ft26">PTEN regulates planarian adult stem cells</p>
<p style="position:absolute;top:28px;left:63px;white-space:nowrap" class="ft27"><b>RESEARCH ARTICLE</b></p>
<p style="position:absolute;top:611px;left:634px;white-space:nowrap" class="ft218"><b>Fig. 1.&#160;<i>Smed-PTEN&#160;</i></b><b>phylogenetics and<br/>expression studies.&#160;</b>(A) Bayesian analysis of<br/>PTEN family members shown as an unrooted<br/>tree with relative branch lengths. Bootstrap<br/>support is shown for each node. Species<br/>used:&#160;<i>Smed&#160;</i>(<i>Schmidtea mediterranea</i>),&#160;<i>Hs<br/></i>(<i>Homo sapiens</i>),&#160;<i>Tr&#160;</i>(<i>Takifugu rubripes</i>),&#160;<i>Xl<br/></i>(<i>Xenopus laevis</i>),&#160;<i>Dm&#160;</i>(<i>Drosophila<br/>melanogaster</i>). (B, C) Representative whole-<br/>mount ISH in intact worms showing the<br/>widely distributed expression patterns<br/>(purple precipitation) for both&#160;<i>Smed-PTEN-1<br/></i>and&#160;<i>Smed-PTEN-2</i>, respectively. In both cases<br/>anterior is at the top; bars, 100&#160;</p>
<p style="position:absolute;top:803px;left:785px;white-space:nowrap" class="ft210">μm. A more</p>
<p style="position:absolute;top:821px;left:634px;white-space:nowrap" class="ft218">detailed view of the expression patterns,<br/>including area in front of the<br/>photoreceptors, can be visualized at higher<br/>magnifications for both genes, as well as<br/>from tissue sections. PR: photoreceptors; CG:<br/>cephalic ganglia. (D)&#160;<i>Smed-PTEN-1&#160;</i>and<br/><i>Smed-PTEN-2&#160;</i>qRT-PCR from different cell<br/>populations isolated by flow cytometry.<br/>Note that both genes are expressed in<br/>irradiation sensitive (X1 and X2) and<br/>insensitive (Xins) cells, consistent with the<br/>wide distribution observed in whole-mount<br/>ISH results. Expression levels are relative to<br/>the standard internal control clone<br/>(<i>H.55.12e</i>). Numbers are expressed as the<br/>average of triplicate experiments (± s.d.)<br/>from two different preparations.</p>
<p style="position:absolute;top:728px;left:45px;white-space:nowrap" class="ft212"><i>D</i></p>
<p style="position:absolute;top:715px;left:45px;white-space:nowrap" class="ft212"><i>isease Models &amp; Mechanisms &#160; &#160; &#160; &#160;&#160;</i></p>
<p style="position:absolute;top:466px;left:45px;white-space:nowrap" class="ft212"><i>DMM</i></p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>eb7bcef887a877066e2c932dee6d95a6-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft30{font-size:11px;font-family:Times;color:#231f20;}
	.ft31{font-size:11px;font-family:Times;color:#231f20;}
	.ft32{font-size:12px;font-family:Times;color:#231f20;}
	.ft33{font-size:12px;font-family:Times;color:#231f20;}
	.ft34{font-size:9px;font-family:Times;color:#261e5a;}
	.ft35{font-size:9px;font-family:Times;color:#231f20;}
	.ft36{font-size:9px;font-family:Times;color:#231f20;}
	.ft37{font-size:17px;font-family:Times;color:#261e5a;}
	.ft38{font-size:10px;font-family:Times;color:#231f20;}
	.ft39{font-size:10px;font-family:Times;color:#231f20;}
	.ft310{font-size:10px;font-family:Times;color:#231f20;}
	.ft311{font-size:19px;font-family:Times;color:#261e5a;-moz-transform: matrix(         0,         -1,          1,          0, 0, 0);-webkit-transform: matrix(         0,         -1,          1,          0, 0, 0);-o-transform: matrix(         0,         -1,          1,          0, 0, 0);-ms-transform: matrix(         0,         -1,          1,          0, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft312{font-size:11px;line-height:17px;font-family:Times;color:#231f20;}
	.ft313{font-size:11px;line-height:16px;font-family:Times;color:#231f20;}
	.ft314{font-size:12px;line-height:17px;font-family:Times;color:#231f20;}
	.ft315{font-size:12px;line-height:17px;font-family:Times;color:#231f20;}
	.ft316{font-size:10px;line-height:15px;font-family:Times;color:#231f20;}
	.ft317{font-size:10px;line-height:15px;font-family:Times;color:#231f20;}
	.ft318{font-size:10px;line-height:14px;font-family:Times;color:#231f20;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page3-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:101px;left:64px;white-space:nowrap" class="ft314"><i><b>Smed-PTEN&#160;</b></i><b>genes are expressed in neoblasts and differentiated<br/>cells<br/></b>The general expression patterns of&#160;<i>Smed-PTEN-1&#160;</i>and&#160;&#160;<i>Smed-<br/>PTEN-2</i></p>
<p style="position:absolute;top:151px;left:117px;white-space:nowrap" class="ft32">were defined using whole-mount in situ hybridizations</p>
<p style="position:absolute;top:168px;left:64px;white-space:nowrap" class="ft315">(ISH). Expression for both genes (Fig. 1B,C) is detected throughout<br/>mesenchymal tissues (dorsal/ventral and anterior/posterior),<br/>including postmitotic areas (i.e. the area in front of the<br/>photoreceptors and the pharynx). No obvious restriction to a<br/>particular organ system was observed; however, spatial expression<br/>patterns differ in that the&#160;<i>Smed-PTEN-1&#160;</i>signal is dispersed, whereas<br/><i>Smed-PTEN-2</i></p>
<p style="position:absolute;top:270px;left:150px;white-space:nowrap" class="ft32">expression is detected&#160;in defined clusters throughout</p>
<p style="position:absolute;top:287px;left:64px;white-space:nowrap" class="ft314">the mesenchyme (Fig. 1B,C). Expression patterns were confirmed<br/>as specific by performing several optimization rounds of the ISH<br/>protocol and standardizing the results with control probes of known<br/>expression patterns. Additionally, ISH with sense probes in wild-<br/>type worms and antisense probes in RNAi worms, for each&#160;<i>Smed-<br/>PTEN</i></p>
<p style="position:absolute;top:372px;left:113px;white-space:nowrap" class="ft32">gene confirmed the detected expression patterns</p>
<p style="position:absolute;top:389px;left:64px;white-space:nowrap" class="ft32">(supplementary material Fig. S1 and data not shown).</p>
<p style="position:absolute;top:406px;left:79px;white-space:nowrap" class="ft32">Because the spatial signal distribution precluded&#160;us from defining</p>
<p style="position:absolute;top:423px;left:64px;white-space:nowrap" class="ft315">the cell types expressing&#160;<i>Smed-PTEN-1&#160;</i>and&#160;&#160;<i>Smed-PTEN-2</i>, we<br/>performed quantitative real-time PCR (qRT-PCR) analyses on<br/>diverse cell populations isolated&#160;by fluorescence activated&#160;cell<br/>sorting (FACS) (Fig. 1D). We tested the irradiation-sensitive cells<br/>comprised by the X1 and X2 populations, and the irradiation-<br/>insensitive cell types represented by the Xins area of the FACS<br/>profile (Hayashi et al., 2006; Reddien et al., 2005b). These<br/>experiments revealed that expression of both&#160;<i>Smed-PTEN&#160;</i>genes<br/>is detectable in all three cell subpopulations (Fig. 1D). These data<br/>suggest that the expression of&#160;<i>Smed-PTEN-1&#160;</i>and&#160;<i>Smed-PTEN-2&#160;</i>is<br/>widespread and includes neoblasts.</p>
<p style="position:absolute;top:628px;left:64px;white-space:nowrap" class="ft315"><b>Silencing of&#160;<i>Smed-PTEN</i></b><b>-<i>1&#160;</i></b><b>and&#160;<i>Smed-PTEN-2&#160;</i></b><b>results in abnormal<br/>tissue growth and lethality<br/></b>RNAi experiments were performed to abolish the expression of<br/>each&#160;<i>Smed-PTEN&#160;</i>gene individually or simultaneously. We designed<br/>and optimized a double-stranded RNA (dsRNA) microinjection<br/>schedule that consistently reproduces a particular phenotype (see<br/>below). This procedure requires a total of five microinjections<br/>distributed&#160;through 11 days (Fig. 2A). The dsRNA was synthesized<br/>in vitro according to standard protocols (Sánchez Alvarado and<br/>Newmark, 1999)&#160;and injected at different intervals during the<br/>schedule (Fig. 2A). Throughout the experiment, all groups were<br/>extensively evaluated under the microscope and scored&#160;for<br/>anatomical and/or behavioral changes (Reddien et al., 2005a).<br/>Additionally, abrogation of gene expression was confirmed by RT-<br/>PCR and whole-mount ISH (supplementary material Fig. S1 and<br/>data&#160;not shown).</p>
<p style="position:absolute;top:900px;left:79px;white-space:nowrap" class="ft32">Representative results from different&#160;groups of animals,&#160;12 days</p>
<p style="position:absolute;top:917px;left:64px;white-space:nowrap" class="ft315">after the first microinjection, are shown in Fig. 2B. Planarians<br/>injected with water (control), dsRNA-<i>Smed-PTEN-1&#160;</i>or&#160;dsRNA-<br/><i>Smed-PTEN-2</i></p>
<p style="position:absolute;top:951px;left:152px;white-space:nowrap" class="ft32">were indistinguishable from each other (Fig. 2B left</p>
<p style="position:absolute;top:968px;left:64px;white-space:nowrap" class="ft315">panels). In contrast, all&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>worms (<i>n</i>&gt;100)<br/>displayed behavioral and anatomical changes followed by death<br/>(100% penetrance). Signs of the phenotype began with a slowing<br/>of movements and a lack of normal photophobic response, followed<br/>by reabsorbtion of the most anterior area in front of the<br/>photoreceptors (head regression). Head regression in planarians is<br/>associated with&#160;impaired&#160;neoblast function (Guo et&#160;al., 2006;</p>
<p style="position:absolute;top:628px;left:468px;white-space:nowrap" class="ft314">Reddien et al., 2005a; Reddien et al., 2005b); however, this<br/>phenotype is normally accompanied by a characteristic ventral<br/>curling, which did not occur at any time in&#160;<i>Smed-PTEN-1, -2(RNAi)<br/></i>worms. Instead, as the phenotype progressed, abnormal growths<br/>became evident in different body parts, but tended to be more<br/>severe at anterior ends (Fig. 2B, arrows). These abnormal growths<br/>increased rapidly in size and number, and worms eventually began<br/>to&#160;lyse&#160;and die three to&#160;four days after the first obvious signs of the<br/>phenotype (supplementary material Table S1). In the majority of<br/>cases, these changes were most evident after the final injection<br/>(11±2.2 days after the first injection, average ± standard deviation<br/>[s.d.]); representative images of the phenotype (12 days after first<br/>injection) with different degrees of severity are shown in Fig. 2B<br/>(right&#160;panel). These data&#160;indicate that&#160;<i>Smed-PTEN-1&#160;</i>and&#160;&#160;<i>Smed-<br/>PTEN-2</i></p>
<p style="position:absolute;top:866px;left:519px;white-space:nowrap" class="ft32">functionally compensate each other, and that these genes</p>
<p style="position:absolute;top:883px;left:468px;white-space:nowrap" class="ft315">play&#160;a role in regulating proper neoblast functions that&#160;may differ<br/>from those observed following either irradiation or silencing of<br/><i>smedwi-2&#160;</i></p>
<p style="position:absolute;top:917px;left:527px;white-space:nowrap" class="ft32">(a gene involved in the regulation of planarian stem cells)</p>
<p style="position:absolute;top:934px;left:468px;white-space:nowrap" class="ft32">(Reddien et al., 2005b).</p>
<p style="position:absolute;top:968px;left:468px;white-space:nowrap" class="ft315"><i><b>Smed-PTEN-1&#160;</b></i><b>and&#160;<i>Smed-PTEN-2&#160;</i></b><b>are required for regeneration<br/></b>To determine whether&#160;<i>Smed-PTEN&#160;</i>genes play&#160;a role during<br/>regeneration, we performed an RNAi time-course strategy similar<br/>to that carried out in intact worms, except that animals were<br/>amputated at&#160;pre/postpharyngeal levels one day after the third<br/>injection (Fig. 3A). Trunk fragments resulting from these amputations<br/>received two additional injections (days 1 and 3 post-amputation);</p>
<p style="position:absolute;top:1100px;left:64px;white-space:nowrap" class="ft34"><b>Disease Models &amp; Mechanisms</b></p>
<p style="position:absolute;top:1100px;left:836px;white-space:nowrap" class="ft35"><b>133</b></p>
<p style="position:absolute;top:35px;left:64px;white-space:nowrap" class="ft36">PTEN regulates planarian adult stem cells</p>
<p style="position:absolute;top:28px;left:678px;white-space:nowrap" class="ft37"><b>RESEARCH ARTICLE</b></p>
<p style="position:absolute;top:377px;left:468px;white-space:nowrap" class="ft316"><b>Fig. 2. Microinjection schedule and its effect&#160;in intact planarians.&#160;</b>(A)<br/>Microinjection schedule in intact planarians. A total of five injections (arrows)<br/>were performed during 11 days (dashed line). Injections were administered at<br/>different intervals (days), illustrated by numbers between arrows. (B)<br/>Representative images from experimental groups following 11 or more days<br/>after the first injection. Conditions shown: control (water-injected),&#160;<i>Smed-<br/>PTEN-1(RNAi)</i>,&#160;<i>Smed-PTEN-2(RNAi)&#160;</i>and simultaneous&#160;<i>Smed-PTEN-1, -2(RNAi).&#160;</i>We<br/>did not observe any external differences between the first three conditions<br/>(left column), while in simultaneous RNAi animals important behavioral and<br/>macroscopic abnormalities were noted. Initial signs of the phenotypes<br/>(illustrated from top left to bottom, white arrows) began with lethargic<br/>movements and tissue regression in front of the photoreceptors, followed by<br/>development of external outgrowths and lysis. In all cases anterior end is to<br/>the left. Bar, 500&#160;</p>
<p style="position:absolute;top:569px;left:549px;white-space:nowrap" class="ft39">μm.</p>
<p style="position:absolute;top:728px;left:45px;white-space:nowrap" class="ft311"><i>D</i></p>
<p style="position:absolute;top:715px;left:45px;white-space:nowrap" class="ft311"><i>isease Models &amp; Mechanisms &#160; &#160; &#160; &#160;&#160;</i></p>
<p style="position:absolute;top:466px;left:45px;white-space:nowrap" class="ft311"><i>DMM</i></p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>eb7bcef887a877066e2c932dee6d95a6-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft40{font-size:12px;font-family:Times;color:#231f20;}
	.ft41{font-size:12px;font-family:Times;color:#231f20;}
	.ft42{font-size:11px;font-family:Times;color:#231f20;}
	.ft43{font-size:11px;font-family:Times;color:#231f20;}
	.ft44{font-size:9px;font-family:Times;color:#261e5a;}
	.ft45{font-size:9px;font-family:Times;color:#231f20;}
	.ft46{font-size:9px;font-family:Times;color:#231f20;}
	.ft47{font-size:17px;font-family:Times;color:#261e5a;}
	.ft48{font-size:10px;font-family:Times;color:#231f20;}
	.ft49{font-size:10px;font-family:Times;color:#231f20;}
	.ft410{font-size:10px;font-family:Times;color:#231f20;}
	.ft411{font-size:19px;font-family:Times;color:#261e5a;-moz-transform: matrix(         0,         -1,          1,          0, 0, 0);-webkit-transform: matrix(         0,         -1,          1,          0, 0, 0);-o-transform: matrix(         0,         -1,          1,          0, 0, 0);-ms-transform: matrix(         0,         -1,          1,          0, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft412{font-size:12px;line-height:17px;font-family:Times;color:#231f20;}
	.ft413{font-size:12px;line-height:17px;font-family:Times;color:#231f20;}
	.ft414{font-size:11px;line-height:17px;font-family:Times;color:#231f20;}
	.ft415{font-size:11px;line-height:16px;font-family:Times;color:#231f20;}
	.ft416{font-size:10px;line-height:15px;font-family:Times;color:#231f20;}
	.ft417{font-size:10px;line-height:15px;font-family:Times;color:#231f20;}
	.ft418{font-size:10px;line-height:14px;font-family:Times;color:#231f20;}
	.ft419{font-size:10px;line-height:15px;font-family:Times;color:#231f20;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page4-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:696px;left:64px;white-space:nowrap" class="ft413">subsequent behavioral and anatomical changes were evaluated<br/>(Reddien et al., 2005a). Animals subjected to either&#160;<i>Smed-PTEN-<br/>1(RNAi)</i></p>
<p style="position:absolute;top:730px;left:115px;white-space:nowrap" class="ft40">or&#160;<i>Smed-PTEN-2(RNAi)&#160;</i>developed anterior and posterior</p>
<p style="position:absolute;top:747px;left:64px;white-space:nowrap" class="ft412">regeneration blastemas, with macroscopic regenerative dynamics that<br/>were indistinguishable from those observed in control animals (i.e.<br/>normal wound healing, blastema formation, photoreceptor<br/>pigmentation, photophobic response, etc.; Fig. 3B, left panels). In<br/>contrast, the&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>worms showed normal wound<br/>healing, but failed to form blastemas and by approximately the second<br/>day post-amputation (10±0.8 days after the first injection) signs of<br/>the phenotype (no blastema formation, scattered outgrowths) were<br/>evident in all animals (<i>n</i></p>
<p style="position:absolute;top:879px;left:197px;white-space:nowrap" class="ft40">=47/47). These abnormal growths multiplied</p>
<p style="position:absolute;top:900px;left:64px;white-space:nowrap" class="ft412">and within one week after amputation (6.25±3.3 days) all animals<br/>were dead (Fig. 3B, right panel). These results are consistent with<br/>the effect observed for&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>in intact worms<br/>(supplementary&#160;material Table S1). Furthermore, in both&#160;uncut and<br/>regenerating animals, overt signs of the phenotype were noted at<br/>similar times after the first injection (~11 days; Student’s&#160;<i>t</i>-test,<br/><i>P</i></p>
<p style="position:absolute;top:998px;left:72px;white-space:nowrap" class="ft40">=0.25), suggesting that under these conditions amputation does not</p>
<p style="position:absolute;top:1019px;left:64px;white-space:nowrap" class="ft412">influence phenotype dynamics. These results support our previous<br/>conclusion that&#160;<i>Smed-PTEN-1&#160;</i>and&#160;<i>Smed-PTEN-2&#160;</i>are required for<br/>proper neoblast function and indicate that the planarian PTEN<br/>orthologs are necessary&#160;for blastema formation.</p>
<p style="position:absolute;top:101px;left:468px;white-space:nowrap" class="ft412"><b>Disorganization of differentiated tissues and cellular infiltration<br/>occur in the absence of PTEN function<br/></b>We&#160;sought&#160;to better understand the cellular basis for the observed<br/>phenotype in&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>animals. We first performed<br/>fluorescent immunohistochemistry with antibodies specific to<br/>differentiated tissues,&#160;specifically neurons, muscle and cilia (Cebrià<br/>et al., 1996; Robb and Sánchez Alvarado, 2002; Sakai et al., 2000).<br/>Results from these experiments revealed unexpected and severe<br/>disruptions to the anatomical and functional integrity of these<br/>tissues (Fig. 4). Photoreceptor neurons were found in disarray, and<br/>were&#160;often dispersed&#160;and lacking optic chiasmatas (Fig. 4A); body<br/>wall musculature displayed areas devoid of myosin positive cells<br/>(Fig. 4B); and the surface area of dorsal cilia fields was reduced<br/>(Fig. 4C). Such defects are consistent with the idea that tissue<br/>maintenance by neoblasts and their progeny are compromised after<br/>silencing of&#160;<i>Smed-PTEN-1&#160;</i>and&#160;<i>Smed-PTEN-2</i>.</p>
<p style="position:absolute;top:372px;left:483px;white-space:nowrap" class="ft40">Histological analyses&#160;of RNAi-treated&#160;animals not only</p>
<p style="position:absolute;top:389px;left:468px;white-space:nowrap" class="ft413">confirmed the tissue disorganization detected&#160;by immunohistology,<br/>but also uncovered discontinuities in the basement membrane (BM)<br/>and the presence of abnormal invasive cells (Fig. 4D,E). The BM<br/>(extracellular matrix underneath the epithelial cells; Fig. 4D, lower<br/>arrows) separates the epithelium from the underlying mesenchyme<br/>(Nelson and Bissell, 2006). In the&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>animals,<br/>the integrity of the BM is markedly disrupted, and in some areas<br/>a physical barrier separating epithelial cells and mesenchymal<br/>tissues cannot be detected (Fig. 4E, top right). Such direct contact<br/>between epithelium and mesenchyme is also observed in planarians<br/>during normal wound healing after amputation and is known to<br/>be involved in the proliferation of nearby neoblasts (Hori, 1979a;<br/>Hori, 1979b; Hori, 1980). This may explain, in part, the<br/>overproliferation of cells detected in&#160;<i>Smed-PTEN-1, -2(RNAi)<br/></i>animals.</p>
<p style="position:absolute;top:644px;left:483px;white-space:nowrap" class="ft40">The abnormal invasiveness of some cells in&#160;<i>Smed-PTEN-1,</i></p>
<p style="position:absolute;top:661px;left:468px;white-space:nowrap" class="ft41"><i>-2(RNAi)&#160;</i></p>
<p style="position:absolute;top:661px;left:527px;white-space:nowrap" class="ft40">animals was readily apparent in the pharynx (Fig. 4E,</p>
<p style="position:absolute;top:678px;left:468px;white-space:nowrap" class="ft412">bottom right). Normally, postmitotic progeny of neoblasts migrate<br/>to the epithelium and pharynx to replace cells lost during cellular<br/>turnover and tissue regeneration (Newmark and Sánchez Alvarado,<br/>2000). Although, in the&#160;<i>Smed-PTEN&#160;</i>phenotype no ectopic mitotic<br/>activity was noted (i.e. no mitotic figures were detected in front of<br/>the photoreceptors or pharynx; see Fig. 4G), the cellular infiltration<br/>(i.e. increase&#160;in cellularity in different&#160;organs) observed&#160;in the<br/>epithelium and pharynx (Fig. 4E) may be due to the migration of<br/>neoblast progeny. Bromodeoxyuridine (BrdU) experiments<br/>confirmed that the migratory ability of the neoblast progeny was<br/>not lost after abrogation of&#160;<i>Smed-PTEN&#160;</i>genes (data not shown).<br/>Additionally, these cellular infiltrations were characterized by the<br/>presence of basophilic cells (Fig. 4E).</p>
<p style="position:absolute;top:917px;left:468px;white-space:nowrap" class="ft412"><i><b>Smed-PTEN-1&#160;</b></i><b>and&#160;<i>Smed-PTEN-2&#160;</i></b><b>affect neoblast proliferation and<br/>cell number<br/></b>To further characterize the&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>phenotype,<br/>we examined whether cell number and the anatomical composition<br/>of different&#160;tissue types were&#160;affected. First,&#160;we dissociated control<br/>and&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>planarians (<i>n</i></p>
<p style="position:absolute;top:998px;left:715px;white-space:nowrap" class="ft40">=10 for each group) into</p>
<p style="position:absolute;top:1019px;left:468px;white-space:nowrap" class="ft412">cell suspensions of equal volume. The cells were spotted onto slides<br/>and the nuclei counterstained with propidium iodide (PI) (see<br/>experimental procedures for details). PI signal quantification<br/>revealed an increase of ~20% in cell number in&#160;<i>Smed-PTEN-1,</i></p>
<p style="position:absolute;top:1100px;left:756px;white-space:nowrap" class="ft44"><b>dmm.biologists.org</b></p>
<p style="position:absolute;top:1100px;left:64px;white-space:nowrap" class="ft45"><b>134</b></p>
<p style="position:absolute;top:35px;left:670px;white-space:nowrap" class="ft46">PTEN regulates planarian adult stem cells</p>
<p style="position:absolute;top:28px;left:63px;white-space:nowrap" class="ft47"><b>RESEARCH ARTICLE</b></p>
<p style="position:absolute;top:381px;left:64px;white-space:nowrap" class="ft417"><b>Fig. 3. Microinjection schedule and its effects&#160;during tissue regeneration.<br/></b>(A) Microinjection schedule. A total of five injections (arrows) were performed<br/>during 11 days (top dashed line). Injections were administered at different<br/>intervals (numbers between arrows). The blue arrow depicts the stage at<br/>which bipolar amputation was performed and the dashed line (gray) at the<br/>bottom highlights the experimentation period during which animals were<br/>either intact or under regeneration. (B) Representative images of experimental<br/>groups between three and eight days post-amputation (the amputation level<br/>is represented by the white dashed line). Conditions shown: control (water-<br/>injected),&#160;<i>Smed-PTEN-1(RNAi)</i>,&#160;<i>Smed-PTEN-2(RNAi),&#160;</i>and simultaneous&#160;<i>Smed-<br/>PTEN-1, -2(RNAi)</i>. No external differences were observed during anterior or<br/>posterior blastema formation (unpigmented tissue formed after amputation)<br/>between the first three conditions (left column), whereas in simultaneous<br/>RNAi fragments, important behavioral and macroscopic abnormalities were<br/>noted (<i>n</i></p>
<p style="position:absolute;top:588px;left:106px;white-space:nowrap" class="ft49">=47/47 worms, similar numbers for each group were run in parallel).</p>
<p style="position:absolute;top:606px;left:64px;white-space:nowrap" class="ft417">Abnormal outgrowths (white arrows) were evidenced in different parts of the<br/>animal (including the tissue surrounding the amputation area) followed by<br/>lysis shortly after visualization of the first sign of the phenotype. In all cases<br/>anterior is to the left. Bar, 500&#160;</p>
<p style="position:absolute;top:648px;left:209px;white-space:nowrap" class="ft49">μm.</p>
<p style="position:absolute;top:728px;left:45px;white-space:nowrap" class="ft411"><i>D</i></p>
<p style="position:absolute;top:715px;left:45px;white-space:nowrap" class="ft411"><i>isease Models &amp; Mechanisms &#160; &#160; &#160; &#160;&#160;</i></p>
<p style="position:absolute;top:466px;left:45px;white-space:nowrap" class="ft411"><i>DMM</i></p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>eb7bcef887a877066e2c932dee6d95a6-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft50{font-size:12px;font-family:Times;color:#231f20;}
	.ft51{font-size:12px;font-family:Times;color:#231f20;}
	.ft52{font-size:9px;font-family:Times;color:#261e5a;}
	.ft53{font-size:9px;font-family:Times;color:#231f20;}
	.ft54{font-size:9px;font-family:Times;color:#231f20;}
	.ft55{font-size:17px;font-family:Times;color:#261e5a;}
	.ft56{font-size:10px;font-family:Times;color:#231f20;}
	.ft57{font-size:10px;font-family:Times;color:#231f20;}
	.ft58{font-size:10px;font-family:Times;color:#231f20;}
	.ft59{font-size:10px;font-family:Times;color:#231f20;}
	.ft510{font-size:19px;font-family:Times;color:#261e5a;-moz-transform: matrix(         0,         -1,          1,          0, 0, 0);-webkit-transform: matrix(         0,         -1,          1,          0, 0, 0);-o-transform: matrix(         0,         -1,          1,          0, 0, 0);-ms-transform: matrix(         0,         -1,          1,          0, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft511{font-size:12px;line-height:17px;font-family:Times;color:#231f20;}
	.ft512{font-size:12px;line-height:17px;font-family:Times;color:#231f20;}
	.ft513{font-size:10px;line-height:15px;font-family:Times;color:#231f20;}
	.ft514{font-size:10px;line-height:15px;font-family:Times;color:#231f20;}
	.ft515{font-size:10px;line-height:17px;font-family:Times;color:#231f20;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page5-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:951px;left:64px;white-space:nowrap" class="ft50"><i>-2(RNAi)</i></p>
<p style="position:absolute;top:951px;left:123px;white-space:nowrap" class="ft51">worms;&#160;however, this increase&#160;in cell number was not</p>
<p style="position:absolute;top:968px;left:64px;white-space:nowrap" class="ft511">associated with&#160;increases in animal length&#160;or cell size (Fig. 4F and<br/>data&#160;not shown). Qualitative anatomical analyses&#160;(visual inspection<br/>of nuclei counterstaining using Sytox green, Molecular Probes) were<br/>also performed in cross-sections of different areas (anterior,<br/>posterior) and revealed that the increase in cell number/density in<br/>the&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>phenotype was scattered rather than<br/>restricted to a specific tissue or organ (data not shown). However,</p>
<p style="position:absolute;top:951px;left:468px;white-space:nowrap" class="ft51">in animals with a severe phenotype (<i>n</i></p>
<p style="position:absolute;top:947px;left:696px;white-space:nowrap" class="ft51">=5), we observed evidence</p>
<p style="position:absolute;top:968px;left:468px;white-space:nowrap" class="ft512">for the occurrence of hyperplasia,&#160;in which&#160;the normally<br/>monolayered&#160;epidermis became multilayered&#160;in&#160;<i>Smed-PTEN-1,<br/>-2(RNAi)</i></p>
<p style="position:absolute;top:1002px;left:524px;white-space:nowrap" class="ft51">animals (Fig. 4F). This finding is consistent with&#160;previous</p>
<p style="position:absolute;top:1019px;left:468px;white-space:nowrap" class="ft511">chemically-induced epithelial hyperplasia observed in planarian<br/>neoplasms (Foster,&#160;1963).</p>
<p style="position:absolute;top:1053px;left:483px;white-space:nowrap" class="ft51">Because neoblasts are the only known proliferative cell type in</p>
<p style="position:absolute;top:1070px;left:468px;white-space:nowrap" class="ft51">asexual planarians, we sought&#160;to&#160;evaluate&#160;whether cell proliferation</p>
<p style="position:absolute;top:1100px;left:64px;white-space:nowrap" class="ft52"><b>Disease Models &amp; Mechanisms</b></p>
<p style="position:absolute;top:1100px;left:836px;white-space:nowrap" class="ft53"><b>135</b></p>
<p style="position:absolute;top:35px;left:64px;white-space:nowrap" class="ft54">PTEN regulates planarian adult stem cells</p>
<p style="position:absolute;top:28px;left:678px;white-space:nowrap" class="ft55"><b>RESEARCH ARTICLE</b></p>
<p style="position:absolute;top:645px;left:64px;white-space:nowrap" class="ft514"><b>Fig. 4. The&#160;<i>Smed-PTEN&#160;</i></b><b>phenotype is characterized by a lack of tissue maintenance, tissue architecture disorganization and neoblast hyperproliferation.<br/></b>(A-C) Representative confocal images (anterior, dorsal views) from control (water-injected) worms (left column in A-C) and&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>worms&#160;(right<br/>column), respectively. Immunostaining was performed by using different tissue markers: neuronal marker (anti-arrestin, VC-1) (A); muscle (anti-myosin heavy<br/>chain, TMUS-13) (B); and epithelium (anti-</p>
<p style="position:absolute;top:687px;left:268px;white-space:nowrap" class="ft58">α&#160;acetylated tubulin) (C) antibodies, respectively. White arrows are used to indicate morphological disruptions. Bar, 100</p>
<p style="position:absolute;top:702px;left:64px;white-space:nowrap" class="ft514">μm. (D, E) Tissue disorganization and cellular infiltration in the&#160;<i>Smed-PTEN&#160;</i>phenotype. Representative images of paraffin-tissue sections stained with hematoxylin<br/>and eosin from control (D) and&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>(E) worms showing similar anatomical areas, illustrating dorsal epithelium (prepharyngeal area) and<br/>pharynx. Green arrowheads in the top panel of (D) indicate the columnar epithelium and basement membrane of control animals. The green arrowheads in the<br/>top panel of (E) denote the multiple cell layers in the epithelium and the disruption of basement membrane in&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>animals. The bottom panels<br/>illustrate cross-sections of the dorsal epithelium of the pharyngeal area, along with part of the pharynx (the large ovoid-shaped structure). Note the cellular<br/>infiltration in the pharynx of&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>worms, with cells possessing morphology similar to that described for neoblasts (i.e. rounded cells with large<br/>nuclei and scant cytoplasm), consistent with a neoblastoma (Best and Morita, 1982). Bars, 20&#160;</p>
<p style="position:absolute;top:792px;left:518px;white-space:nowrap" class="ft58">μm. (F) Cross sections (10&#160;μm thickness) of the anterior end, with</p>
<p style="position:absolute;top:810px;left:64px;white-space:nowrap" class="ft514">nuclei counterstaining (Sytox green) in both control worms (top) and&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>worms &gt;12 days after the first dsRNA injection (bottom). Notice the<br/>anatomical disruption (white arrow) and the multiple cell layers of the epithelium (insets). Numbers represent the total count&#160;from nuclei counterstaining in<br/>control (<i>n</i></p>
<p style="position:absolute;top:837px;left:111px;white-space:nowrap" class="ft58">=730) and&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>worms (<i>n</i>=902), after a pool of worms (<i>n</i>=10) were dissociated (average of cells from three experiments ± s.d.). Dorsal</p>
<p style="position:absolute;top:855px;left:64px;white-space:nowrap" class="ft58">side is to the top. CG: cephalic ganglia; GVS: gastrovascular system. Bar, 0.2 mm. (G) Representative images of whole-mount immunostaining using&#160;</p>
<p style="position:absolute;top:852px;left:783px;white-space:nowrap" class="ft58">α-</p>
<p style="position:absolute;top:870px;left:64px;white-space:nowrap" class="ft514">phosphorylated histone H3 (H3P) antibody in intact worms (12 days after first injection). Control (water-injected) and&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>worms are shown.<br/>(G’) H3P-signal quantification from both control and simultaneous&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>worms. A significant increase (<i>P</i>&lt;0.0001) in mitotic activity was<br/>observed in RNAi treated animals. Mitotic activity in control worms and following individual&#160;<i>Smed-PTEN&#160;</i>RNAi treatments was qualitatively and quantitatively<br/>indistinguishable between the groups (data not shown). Results represent average ± s.d. from&#160;<i>n</i></p>
<p style="position:absolute;top:912px;left:532px;white-space:nowrap" class="ft58">⭓10 worms in each condition.</p>
<p style="position:absolute;top:728px;left:45px;white-space:nowrap" class="ft510"><i>D</i></p>
<p style="position:absolute;top:715px;left:45px;white-space:nowrap" class="ft510"><i>isease Models &amp; Mechanisms &#160; &#160; &#160; &#160;&#160;</i></p>
<p style="position:absolute;top:466px;left:45px;white-space:nowrap" class="ft510"><i>DMM</i></p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>eb7bcef887a877066e2c932dee6d95a6-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft60{font-size:12px;font-family:Times;color:#231f20;}
	.ft61{font-size:12px;font-family:Times;color:#231f20;}
	.ft62{font-size:11px;font-family:Times;color:#231f20;}
	.ft63{font-size:11px;font-family:Times;color:#231f20;}
	.ft64{font-size:9px;font-family:Times;color:#261e5a;}
	.ft65{font-size:9px;font-family:Times;color:#231f20;}
	.ft66{font-size:9px;font-family:Times;color:#231f20;}
	.ft67{font-size:17px;font-family:Times;color:#261e5a;}
	.ft68{font-size:10px;font-family:Times;color:#231f20;}
	.ft69{font-size:10px;font-family:Times;color:#231f20;}
	.ft610{font-size:10px;font-family:Times;color:#231f20;}
	.ft611{font-size:10px;font-family:Times;color:#231f20;}
	.ft612{font-size:19px;font-family:Times;color:#261e5a;-moz-transform: matrix(         0,         -1,          1,          0, 0, 0);-webkit-transform: matrix(         0,         -1,          1,          0, 0, 0);-o-transform: matrix(         0,         -1,          1,          0, 0, 0);-ms-transform: matrix(         0,         -1,          1,          0, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft613{font-size:12px;line-height:17px;font-family:Times;color:#231f20;}
	.ft614{font-size:12px;line-height:17px;font-family:Times;color:#231f20;}
	.ft615{font-size:11px;line-height:16px;font-family:Times;color:#231f20;}
	.ft616{font-size:10px;line-height:15px;font-family:Times;color:#231f20;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page6-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:100px;left:64px;white-space:nowrap" class="ft613">was involved in the increase in cell number observed in&#160;<i>Smed-<br/>PTEN-1, -2(RNAi)</i></p>
<p style="position:absolute;top:117px;left:173px;white-space:nowrap" class="ft60">animals. We assayed whole animals with an anti-</p>
<p style="position:absolute;top:134px;left:64px;white-space:nowrap" class="ft613">phosphorylated histone-3 (H3P) antibody that&#160;specifically labels<br/>mitotic neoblasts (Newmark and Sánchez Alvarado, 2000). When<br/>signs of the&#160;<i>Smed-PTEN&#160;</i>phenotype became visible (12 days after<br/>the first injection, as described above), mitotic activity was<br/>quantified (Reddien et al., 2005a; Reddien et al., 2005b) in four<br/>different groups: 1) control; 2)&#160;<i>Smed-PTEN-1(RNAi)</i>;&#160;3)&#160;&#160;<i>Smed-<br/>PTEN-2 (RNAi)</i></p>
<p style="position:absolute;top:236px;left:165px;white-space:nowrap" class="ft60">and 4)&#160;<i>Smed-PTEN-1, -2(RNAi)</i>. We found no</p>
<p style="position:absolute;top:253px;left:64px;white-space:nowrap" class="ft614">differences in mitotic activity between control animals and animals<br/>in which the&#160;<i>Smed-PTEN&#160;&#160;</i>genes&#160;were individually silenced (data<br/>not shown). However, a significant increase in mitotic cells<br/>(Student’s&#160;<i>t</i>-test,&#160;<i>P</i>&lt;0.001) was observed in&#160;<i>Smed-PTEN-1, -2(RNAi)</i></p>
<p style="position:absolute;top:100px;left:468px;white-space:nowrap" class="ft614">animals (Fig. 4G). These data suggest that loss of PTEN activity in<br/>planarians leads to hyperproliferation and may be responsible for<br/>the observed&#160;hyperplasia (Fig. 4F).</p>
<p style="position:absolute;top:169px;left:468px;white-space:nowrap" class="ft613"><i><b>Smed-PTEN-1&#160;</b></i><b>and&#160;<i>Smed-PTEN-2&#160;</i></b><b>regulate neoblast differentiation<br/></b>To better understand the nature of the effects exerted by PTEN<br/>on neoblasts, we tested&#160;several markers associated&#160;with&#160;neoblast<br/>function. First, we carried out a quantitative analysis based on<br/>ISH, performed in dissociated control and&#160;<i>Smed-PTEN-1,<br/>-2(RNAi)</i></p>
<p style="position:absolute;top:253px;left:528px;white-space:nowrap" class="ft60">animals, which revealed that there was an important</p>
<p style="position:absolute;top:270px;left:468px;white-space:nowrap" class="ft614">increase in cells expressing neoblast markers after abrogation&#160;of<br/>both&#160;&#160;<i>Smed-PTEN&#160;</i>genes (supplementary&#160;material Fig.&#160;S2). This<br/>suggests that, in addition to an increase in mitotic activity, the</p>
<p style="position:absolute;top:1100px;left:756px;white-space:nowrap" class="ft64"><b>dmm.biologists.org</b></p>
<p style="position:absolute;top:1100px;left:64px;white-space:nowrap" class="ft65"><b>136</b></p>
<p style="position:absolute;top:35px;left:670px;white-space:nowrap" class="ft66">PTEN regulates planarian adult stem cells</p>
<p style="position:absolute;top:28px;left:63px;white-space:nowrap" class="ft67"><b>RESEARCH ARTICLE</b></p>
<p style="position:absolute;top:832px;left:64px;white-space:nowrap" class="ft616"><b>Fig. 5. PTEN-RNAi disrupts tissue maintenance and rapamycin treatment compensates for&#160;<i>Smed-PTEN&#160;</i></b><b>loss.&#160;</b>(A) Quantification of cells expressing markers of<br/>differentiated tissues. From a pool of dissociated animals, ISH was performed using probes specific to the nervous (synaptotagmin,&#160;<i>Smed-Syt</i>), excretory (carbonic<br/>anhydrase,&#160;<i>Smed-CA</i>) and digestive (<i>smedinx-9</i>) systems. Representative pictures of cells expressing each marker are shown (black precipitation). Cells expressing<br/>each marker were counted and the average of two independent experiments was recorded as the total number of positive cells per&#160;slide:&#160;<i>Smed-Syt</i>,&#160;<i>n</i></p>
<p style="position:absolute;top:874px;left:776px;white-space:nowrap" class="ft610">=608 and</p>
<p style="position:absolute;top:892px;left:64px;white-space:nowrap" class="ft611"><i>n</i></p>
<p style="position:absolute;top:889px;left:70px;white-space:nowrap" class="ft610">=428;&#160;<i>Smed-CA</i>,&#160;<i>n</i>=109 and&#160;<i>n</i>=94;&#160;<i>smedinx-9</i>,&#160;<i>n</i>=142 and&#160;<i>n</i>=118 for control and&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>worms, respectively. Respective percentage reductions in the</p>
<p style="position:absolute;top:907px;left:64px;white-space:nowrap" class="ft616">number of expressing cells after RNAi are shown. (B) Rapamycin treatment prevents abnormal outgrowths, lethality and rescues regenerative&#160;events in RNAi-treated<br/>animals. Worms subjected to&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>were unable to regenerate, external outgrowths were evident, and the worms failed to survive longer than 7<br/>days post-amputation (<i>n</i></p>
<p style="position:absolute;top:934px;left:182px;white-space:nowrap" class="ft610">=27/27), whereas rapamycin-treated&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>or control worms developed anterior and posterior blastemas, and survived for</p>
<p style="position:absolute;top:952px;left:64px;white-space:nowrap" class="ft610">more than one month after the first dsRNA injection (<i>n</i></p>
<p style="position:absolute;top:949px;left:325px;white-space:nowrap" class="ft610">=29/29). Representative images of rapamycin-treated control and&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>worms are shown. (C)</p>
<p style="position:absolute;top:967px;left:64px;white-space:nowrap" class="ft616">Quantification of mitotic activity. Note that control and rapamycin-treated worms show similar levels of mitotic activity and that in&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>worms,<br/>proliferation was higher (***<i>P</i>&lt; 0.01). However, simultaneous&#160;<i>Smed-PTEN&#160;</i>RNAi and rapamycin treatment prevent abnormal proliferation while keeping proliferative<br/>activity similar to control animals. Displayed values represent average&#160;</p>
<p style="position:absolute;top:994px;left:398px;white-space:nowrap" class="ft610">±&#160;s.d.&#160;of&#160;<i>n</i>⭓8 worms per condition, for at least two independent replications. (D) Expression of</p>
<p style="position:absolute;top:1012px;left:64px;white-space:nowrap" class="ft616">neoblast markers in dissociated worms. An increase in the number of cells expressing each neoblast marker was always observed in&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>worms<br/>after the RNAi treatment, but was prevented with rapamycin treatment (Student’s&#160;<i>t</i>-test, ***<i>P</i>&lt;0.001). (E) Expression of differentiated tissue markers in dissociated<br/>worms. The same pools of animals discussed in Fig. 5D were used to perform ISH with genes expressed in differentiated tissues (<i>Smed-SYT</i>,&#160;<i>Smed-CA&#160;</i>and&#160;<i>smedinx-9</i>).<br/>For panels (D) and (E), dissociations were performed from a pool of ten animals per group and cell numbers represent the average ± s.d. of 20 different fields per slide<br/>with an objective of 20</p>
<p style="position:absolute;top:1069px;left:173px;white-space:nowrap" class="ft610">⫻&#160;magnification. Total numbers of cells expressing each gene per slide are shown. ND: no difference.</p>
<p style="position:absolute;top:728px;left:45px;white-space:nowrap" class="ft612"><i>D</i></p>
<p style="position:absolute;top:715px;left:45px;white-space:nowrap" class="ft612"><i>isease Models &amp; Mechanisms &#160; &#160; &#160; &#160;&#160;</i></p>
<p style="position:absolute;top:466px;left:45px;white-space:nowrap" class="ft612"><i>DMM</i></p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>eb7bcef887a877066e2c932dee6d95a6-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft70{font-size:12px;font-family:Times;color:#231f20;}
	.ft71{font-size:12px;font-family:Times;color:#231f20;}
	.ft72{font-size:11px;font-family:Times;color:#231f20;}
	.ft73{font-size:11px;font-family:Times;color:#231f20;}
	.ft74{font-size:9px;font-family:Times;color:#261e5a;}
	.ft75{font-size:9px;font-family:Times;color:#231f20;}
	.ft76{font-size:9px;font-family:Times;color:#231f20;}
	.ft77{font-size:17px;font-family:Times;color:#261e5a;}
	.ft78{font-size:10px;font-family:Times;color:#231f20;}
	.ft79{font-size:10px;font-family:Times;color:#231f20;}
	.ft710{font-size:10px;font-family:Times;color:#231f20;}
	.ft711{font-size:10px;font-family:Times;color:#231f20;}
	.ft712{font-size:19px;font-family:Times;color:#261e5a;-moz-transform: matrix(         0,         -1,          1,          0, 0, 0);-webkit-transform: matrix(         0,         -1,          1,          0, 0, 0);-o-transform: matrix(         0,         -1,          1,          0, 0, 0);-ms-transform: matrix(         0,         -1,          1,          0, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft713{font-size:12px;line-height:17px;font-family:Times;color:#231f20;}
	.ft714{font-size:12px;line-height:17px;font-family:Times;color:#231f20;}
	.ft715{font-size:11px;line-height:17px;font-family:Times;color:#231f20;}
	.ft716{font-size:11px;line-height:16px;font-family:Times;color:#231f20;}
	.ft717{font-size:10px;line-height:15px;font-family:Times;color:#231f20;}
	.ft718{font-size:10px;line-height:15px;font-family:Times;color:#231f20;}
	.ft719{font-size:10px;line-height:15px;font-family:Times;color:#231f20;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page7-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:100px;left:64px;white-space:nowrap" class="ft713">number of cells expressing neoblast-specific markers increased<br/>in the&#160;<i>Smed-PTEN&#160;</i>phenotype. In contrast, a marked reduction<br/>in the expression of markers for differentiated cells such as<br/>neuronal (<i>Smed-SYT</i>), excretory (<i>Smed-CA</i>) and digestive<br/>(<i>smedinx-9</i>) cells was observed&#160;in&#160;<i>Smed-PTEN-1, -2(RNAi)<br/></i>animals (Fig. 5A). We independently confirmed these results by<br/>qRT-PCR (supplementary material Table S2). The measured<br/>increment in the numbers of both proliferative neoblasts and their<br/>postmitotic progeny is consistent&#160;with&#160;the increase in cell numbers<br/>detected&#160;histologically (Fig. 4F and supplementary&#160;material Fig.<br/>S2) in&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>worms. Taken together, the data<br/>indicate that loss of&#160;<i>Smed-PTEN&#160;</i>function is characterized by an<br/>increase in neoblast numbers,&#160;but also&#160;a decrease&#160;in differentiated<br/>tissues – probably owing to an inability of the neoblast progeny<br/>to&#160;properly&#160;differentiate.</p>
<p style="position:absolute;top:101px;left:468px;white-space:nowrap" class="ft713"><b>Rapamycin prevents abnormalities produced by&#160;<i>Smed-PTEN&#160;</i></b><b>loss of<br/>function<br/></b>PTEN&#160;loss of function is associated&#160;with&#160;activated&#160;PI3K-Akt<br/>signaling pathway in many malignancies related to cancer. The<br/>macrolide rapamycin operates through the multicomplex protein<br/>TOR, and has been shown to be effective in reversing the symptoms<br/>observed in PTEN loss of function models (Guertin and Sabatini,<br/>2007; Sabatini, 2006; Yilmaz et al., 2006). We sought to test whether<br/>the effects of rapamycin in mammals could be recapitulated in<br/>planarians (see experimental procedure for details).</p>
<p style="position:absolute;top:270px;left:483px;white-space:nowrap" class="ft70">Planarians subjected to RNAi of both&#160;<i>Smed-PTEN&#160;&#160;</i>genes and,</p>
<p style="position:absolute;top:287px;left:468px;white-space:nowrap" class="ft713">subsequently, to daily injections of rapamycin, failed to develop any<br/>macroscopic signs of the characteristic&#160;<i>Smed-PTEN&#160;</i>phenotype,<br/>either in the first two weeks (<i>n</i></p>
<p style="position:absolute;top:318px;left:662px;white-space:nowrap" class="ft70">=50/50), or after one month of</p>
<p style="position:absolute;top:338px;left:468px;white-space:nowrap" class="ft70">treatment (<i>n</i></p>
<p style="position:absolute;top:335px;left:541px;white-space:nowrap" class="ft70">=19/20). However, exposure to rapamycin restored the</p>
<p style="position:absolute;top:1100px;left:64px;white-space:nowrap" class="ft74"><b>Disease Models &amp; Mechanisms</b></p>
<p style="position:absolute;top:1100px;left:836px;white-space:nowrap" class="ft75"><b>137</b></p>
<p style="position:absolute;top:35px;left:64px;white-space:nowrap" class="ft76">PTEN regulates planarian adult stem cells</p>
<p style="position:absolute;top:28px;left:678px;white-space:nowrap" class="ft77"><b>RESEARCH ARTICLE</b></p>
<p style="position:absolute;top:387px;left:514px;white-space:nowrap" class="ft718"><b>Fig. 6.&#160;<i>Smed-Akt&#160;</i></b><b>expression analyses in&#160;<i>Smed-PTEN&#160;</i></b><b>phenotype<br/>and proliferative activity in triple RNAi worms.&#160;</b>(A)&#160;<i>Smed-Akt<br/></i>expression in FACS-isolated cells from control and&#160;<i>Smed-PTEN-1, -<br/>2(RNAi)&#160;</i>worms at day 12 after the first injection (<i>n</i></p>
<p style="position:absolute;top:429px;left:756px;white-space:nowrap" class="ft710">=10 per group). ISH</p>
<p style="position:absolute;top:447px;left:514px;white-space:nowrap" class="ft719">was performed in FACS-isolated cells from control and&#160;<i>Smed-PTEN-1,<br/>-2(RNAi)&#160;</i>worms; cells expressing&#160;<i>Smed-Akt&#160;</i>were quantified for each<br/>fraction (see Methods). In control animals,&#160;<i>Smed-Akt&#160;</i>expression levels<br/>are highest in fractions X1 and Xins and comparable to each other<br/>(Student’s&#160;<i>t</i>-test, **<i>P</i></p>
<p style="position:absolute;top:504px;left:612px;white-space:nowrap" class="ft710">=0.24), whereas&#160;<i>Smed-Akt&#160;</i>expression is lowest in</p>
<p style="position:absolute;top:522px;left:514px;white-space:nowrap" class="ft710">the X2 fraction (Student’s&#160;<i>t</i>-test,&#160;<i>P</i></p>
<p style="position:absolute;top:519px;left:677px;white-space:nowrap" class="ft710">&lt;0.0001). In animals treated with</p>
<p style="position:absolute;top:537px;left:514px;white-space:nowrap" class="ft719">dsRNA against both&#160;<i>Smed-PTEN&#160;</i>paralogs, significant increases in<br/><i>Smed-Akt&#160;</i>expressing cells are observed, relative to control worms,<br/>with the greatest increase observed in the X2 fraction (Student’s&#160;<i>t</i>-<br/>test, ***<i>P</i></p>
<p style="position:absolute;top:579px;left:558px;white-space:nowrap" class="ft710">&lt;0.0001). (B)&#160;<i>Smed-Akt&#160;</i>expression in dissociated worms.</p>
<p style="position:absolute;top:597px;left:514px;white-space:nowrap" class="ft710">Pools of animals (<i>n</i></p>
<p style="position:absolute;top:594px;left:605px;white-space:nowrap" class="ft710">=10 each) that had been treated with RNAi,</p>
<p style="position:absolute;top:612px;left:514px;white-space:nowrap" class="ft719">rapamycin, or both, were dissociated and cells expressing&#160;<i>Smed-Akt<br/></i>were quantified.&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>animals showed the highest<br/>number of&#160;<i>Smed-Akt&#160;</i>expressing cells (Student’s&#160;<i>t</i>-test, ***<i>P</i></p>
<p style="position:absolute;top:639px;left:800px;white-space:nowrap" class="ft710">&lt;0.0001).</p>
<p style="position:absolute;top:657px;left:514px;white-space:nowrap" class="ft719">Rapamycin treatment in&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>worms prevented the<br/>increase in&#160;<i>Smed-Akt&#160;</i>expressing cells, but maintained a similar<br/>number to control animals (Student’s&#160;<i>t</i>-test,&#160;<i>P</i></p>
<p style="position:absolute;top:684px;left:735px;white-space:nowrap" class="ft710">=0.5). (C) Mitotic activity</p>
<p style="position:absolute;top:702px;left:514px;white-space:nowrap" class="ft719">in&#160;<i>Smed-Akt(RNAi)&#160;</i>worms,&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>worms or triple<br/>RNAi worms, with or without rapamycin treatment. Animals were<br/>processed for immunostaining 10 days after the first dsRNA-<i>PTEN<br/></i>injection. Mitotic cells were detected in whole animals with H3P<br/>antibody and the signal quantified as described in the Methods (<i>n</i>&gt;6<br/>animals/condition).&#160;<i>Smed-Akt(RNAi)&#160;</i>worms showed a reduced<br/>number of mitotic cells relative to control worms (Student’s&#160;<i>t</i>-test,<br/>*<i>P</i>&lt;0.002). Although, the hyperproliferative defects observed in the<br/><i>Smed-PTEN&#160;</i>phenotype were not prevented in triple RNAi worms<br/>(Student’s&#160;<i>t</i>-test, **<i>P</i></p>
<p style="position:absolute;top:834px;left:612px;white-space:nowrap" class="ft710">=0.3), mitotic activity was significantly reduced to</p>
<p style="position:absolute;top:852px;left:514px;white-space:nowrap" class="ft719">levels comparable with control animals (control vs. triple RNAi,<br/>rapamycin,&#160;<i>P</i></p>
<p style="position:absolute;top:864px;left:576px;white-space:nowrap" class="ft710">=0.5;&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>vs. triple RNAi, rapamycin,</p>
<p style="position:absolute;top:882px;left:514px;white-space:nowrap" class="ft710">Student’s&#160;<i>t</i>-test, ***<i>P</i></p>
<p style="position:absolute;top:879px;left:613px;white-space:nowrap" class="ft710">=0.002). ND: no difference.</p>
<p style="position:absolute;top:728px;left:45px;white-space:nowrap" class="ft712"><i>D</i></p>
<p style="position:absolute;top:715px;left:45px;white-space:nowrap" class="ft712"><i>isease Models &amp; Mechanisms &#160; &#160; &#160; &#160;&#160;</i></p>
<p style="position:absolute;top:466px;left:45px;white-space:nowrap" class="ft712"><i>DMM</i></p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>eb7bcef887a877066e2c932dee6d95a6-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft80{font-size:12px;font-family:Times;color:#231f20;}
	.ft81{font-size:12px;font-family:Times;color:#231f20;}
	.ft82{font-size:11px;font-family:Times;color:#231f20;}
	.ft83{font-size:11px;font-family:Times;color:#231f20;}
	.ft84{font-size:9px;font-family:Times;color:#261e5a;}
	.ft85{font-size:9px;font-family:Times;color:#231f20;}
	.ft86{font-size:9px;font-family:Times;color:#231f20;}
	.ft87{font-size:17px;font-family:Times;color:#261e5a;}
	.ft88{font-size:19px;font-family:Times;color:#261e5a;-moz-transform: matrix(         0,         -1,          1,          0, 0, 0);-webkit-transform: matrix(         0,         -1,          1,          0, 0, 0);-o-transform: matrix(         0,         -1,          1,          0, 0, 0);-ms-transform: matrix(         0,         -1,          1,          0, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft89{font-size:12px;line-height:17px;font-family:Times;color:#231f20;}
	.ft810{font-size:12px;line-height:17px;font-family:Times;color:#231f20;}
	.ft811{font-size:11px;line-height:16px;font-family:Times;color:#231f20;}
	.ft812{font-size:11px;line-height:16px;font-family:Times;color:#231f20;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page8-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:100px;left:64px;white-space:nowrap" class="ft89">ability of&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>animals to launch a regenerative<br/>response after amputation, i.e. rapamycin treatment restored<br/>neoblast proliferation in response to injury. RNAi-treated animals<br/>developed anterior and posterior blastemas with the same dynamics<br/>as&#160;controls&#160;(<i>n</i></p>
<p style="position:absolute;top:165px;left:141px;white-space:nowrap" class="ft80">=30/30), and survived for longer than two weeks after</p>
<p style="position:absolute;top:185px;left:64px;white-space:nowrap" class="ft810">the first dsRNA injection (Fig. 5B). After suspending rapamycin<br/>treatment, only a fraction of worms developed signs of the&#160;<i>Smed-<br/>PTEN</i></p>
<p style="position:absolute;top:219px;left:104px;white-space:nowrap" class="ft80">phenotype within one month (<i>n</i></p>
<p style="position:absolute;top:216px;left:295px;white-space:nowrap" class="ft80">=7/19), indicating that the</p>
<p style="position:absolute;top:236px;left:64px;white-space:nowrap" class="ft810">effect of rapamycin treatment perdures for several weeks. Moreover,<br/>similar levels of mitotic activity were observed among control<br/>worms, worms treated with rapamycin alone, and&#160;<i>Smed-PTEN-1,<br/>-2(RNAi)&#160;</i></p>
<p style="position:absolute;top:287px;left:122px;white-space:nowrap" class="ft80">worms receiving rapamycin, suggesting that rapamycin</p>
<p style="position:absolute;top:304px;left:64px;white-space:nowrap" class="ft89">treatment does not affect basal neoblast proliferation, but<br/>specifically prevents abnormal proliferation in the absence of<br/>functional&#160;<i>Smed-PTEN&#160;</i>genes (Fig. 5C).</p>
<p style="position:absolute;top:355px;left:79px;white-space:nowrap" class="ft80">To further evaluate&#160;the effects of rapamycin in planarians, gene</p>
<p style="position:absolute;top:372px;left:64px;white-space:nowrap" class="ft810">expression analyses were performed using markers of proliferative<br/>and postmitotic progeny of neoblasts (Fig. 5D). The results revealed<br/>that the percentage of cells expressing proliferative and postmitotic<br/>markers is similar between the control groups and rapamycin-<br/>treated&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>worms. However, the expression<br/>of differentiated tissue markers was lower in&#160;<i>Smed-PTEN-1,&#160;-<br/>2(RNAi)</i></p>
<p style="position:absolute;top:474px;left:116px;white-space:nowrap" class="ft80">worms treated with rapamycin than in control worms, or</p>
<p style="position:absolute;top:491px;left:64px;white-space:nowrap" class="ft89">in worms receiving rapamycin alone (Fig. 5E), indicating that<br/>rapamycin may not fully rescue gene expression in differentiated<br/>tissues. Altogether, these results suggest that rapamycin treatment<br/>prevents the tissue homeostasis and regeneration defects observed<br/>in&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>animals.</p>
<p style="position:absolute;top:594px;left:64px;white-space:nowrap" class="ft89"><i><b>Smed-Akt&#160;</b></i><b>expression is upregulated in the&#160;<i>Smed-PTEN&#160;</i></b><b>phenotype<br/></b>The oncoprotein kinase Akt is an important downstream target in<br/>the PI3K pathway that has central roles in PTEN loss of function<br/>(Guertin and Sabatini, 2007; Sabatini, 2006). Thus, we identified<br/>and cloned the planarian&#160;<i>Akt&#160;</i>ortholog (<i>Smed-Akt</i>). Unlike PTEN,<br/>there is a single&#160;<i>Akt&#160;</i>gene in&#160;<i>S. mediterranea</i>.&#160;<i>Smed-Akt&#160;</i>expression<br/>is widely distributed through the mesenchyme including<br/>postmitotic areas and in some cell clusters around the cephalic<br/>ganglia (supplementary&#160;material Fig.&#160;S3).</p>
<p style="position:absolute;top:747px;left:79px;white-space:nowrap" class="ft80">The wide distribution of the&#160;<i>Smed-Akt&#160;</i>signal was also confirmed</p>
<p style="position:absolute;top:764px;left:64px;white-space:nowrap" class="ft810">by expression analyses&#160;of FACS-isolated cells revealing that&#160;<i>Smed-<br/>Akt</i></p>
<p style="position:absolute;top:781px;left:88px;white-space:nowrap" class="ft80">is expressed in approximately 50% of the cells in both the X1</p>
<p style="position:absolute;top:798px;left:64px;white-space:nowrap" class="ft89">(proliferating) and Xins (differentiated) fractions, whereas only<br/>approximately 20% of the cells in X2&#160;express&#160;<i>Smed-Akt&#160;</i>(Fig. 6A).<br/>Strikingly, the distribution of&#160;<i>Smed-Akt&#160;</i>expression was dramatically<br/>altered after simultaneous abrogation of both&#160;<i>Smed-PTEN&#160;</i>genes<br/>(Fig. 6A), increasing significantly in the X1 and X2 compartments<br/>(1.3- and 4.2-fold, respectively), and in differentiated cells<br/>(Xins</p>
<p style="position:absolute;top:896px;left:95px;white-space:nowrap" class="ft80">=&#160;1.6-fold). In fact, the increase in&#160;<i>Smed-Akt&#160;</i>positive cells was</p>
<p style="position:absolute;top:917px;left:64px;white-space:nowrap" class="ft810">higher than that of any other neoblast marker (Fig. 5D), indicating<br/>that&#160;&#160;<i>Smed-PTEN-1&#160;&#160;</i>and&#160;<i>-2&#160;</i>play a role in regulating&#160;<i>Smed-Akt<br/></i>expression in both&#160;neoblasts&#160;and cells of differentiated tissues.<br/>Furthermore, rapamycin treatment of&#160;<i>Smed-PTEN-1, -2(RNAi)<br/></i>worms specifically prevents the abnormal&#160;increase of&#160;<i>Smed-Akt<br/></i>signal, while maintaining its basal expression (Fig. 6B and C). Thus,<br/>rapamycin is not stochastically downregulating&#160;<i>Smed-Akt<br/></i>expression, but it is effective in distinguishing between physiological<br/>levels of&#160;<i>Smed-Akt&#160;</i>and its abnormal expression after RNAi of&#160;<i>Smed-<br/>PTEN-1&#160;</i></p>
<p style="position:absolute;top:1070px;left:116px;white-space:nowrap" class="ft80">and&#160;<i>Smed-PTEN-2.</i></p>
<p style="position:absolute;top:101px;left:468px;white-space:nowrap" class="ft89"><b>RNAi of&#160;<i>Smed-Akt&#160;</i></b><b>does not recapitulate the&#160;<i>Smed-PTEN&#160;</i></b><b>phenotype<br/></b>To&#160;evaluate&#160;the function of&#160;<i>Akt&#160;</i>in the&#160;<i>Smed-PTEN&#160;</i>phenotype, RNAi<br/>experiments involving&#160;<i>Smed-Akt&#160;</i>and&#160;&#160;<i>Smed-PTEN&#160;</i>genes were<br/>carried out. At the gross morphological level,&#160;<i>Smed-Akt(RNAi)<br/></i>animals displayed only locomotion defects (~12 days after first<br/>injection,&#160;&#160;<i>n</i></p>
<p style="position:absolute;top:182px;left:544px;white-space:nowrap" class="ft80">=40/40), and did not develop other external</p>
<p style="position:absolute;top:202px;left:468px;white-space:nowrap" class="ft89">abnormalities or head regression even after more than one month<br/>(data not shown).&#160;<i>Smed-Akt(RNAi)&#160;</i>animals,&#160;however, displayed<br/>lower number of proliferative cells when compared with control<br/>animals (Student’s&#160;<i>t</i>-test,&#160;&#160;<i>P</i>&lt;0.002), suggesting that&#160;<i>Smed-Akt&#160;</i>is<br/>necessary to maintain basal proliferation levels (Fig. 6C).<br/>Nevertheless,&#160;<i>Smed-Akt(RNAi)&#160;</i>animals are still capable of forming<br/>blastemas after amputation and regenerate with similar dynamics<br/>as control animals (data not shown,&#160;<i>n</i></p>
<p style="position:absolute;top:318px;left:693px;white-space:nowrap" class="ft80">=30/30). Together, the data</p>
<p style="position:absolute;top:338px;left:468px;white-space:nowrap" class="ft89">indicate that&#160;<i>Smed-Akt&#160;</i>is not sufficient to affect either long-term<br/>homeostasis or tissue regeneration.</p>
<p style="position:absolute;top:372px;left:483px;white-space:nowrap" class="ft80">Worms subjected to triple RNAi [<i>Smed-Akt(RNAi); Smed-PTEN-</i></p>
<p style="position:absolute;top:389px;left:468px;white-space:nowrap" class="ft81"><i>1, -2(RNAi)</i></p>
<p style="position:absolute;top:389px;left:534px;white-space:nowrap" class="ft80">], with&#160;or without rapamycin treatment,&#160;failed&#160;to&#160;display</p>
<p style="position:absolute;top:406px;left:468px;white-space:nowrap" class="ft89">head regression as observed in the&#160;<i>Smed-PTEN&#160;</i>phenotype, yet<br/>developed abnormal outgrowths and lethality with full penetrance<br/>(<i>n</i></p>
<p style="position:absolute;top:437px;left:480px;white-space:nowrap" class="ft80">=23/23, supplementary material Fig. 4). Moreover, the number</p>
<p style="position:absolute;top:457px;left:468px;white-space:nowrap" class="ft810">of proliferating cells in triple RNAi worms and in&#160;<i>Smed-PTEN-1,<br/>-2(RNAi)</i></p>
<p style="position:absolute;top:474px;left:527px;white-space:nowrap" class="ft80">worms were not statistically different (Student’s&#160;<i>t</i>-test,</p>
<p style="position:absolute;top:491px;left:468px;white-space:nowrap" class="ft81"><i>P</i></p>
<p style="position:absolute;top:491px;left:476px;white-space:nowrap" class="ft80">&gt;0.3). These results suggest that abrogating&#160;<i>Smed-Akt&#160;</i>is not</p>
<p style="position:absolute;top:508px;left:468px;white-space:nowrap" class="ft89">enough to prevent the abnormal hyperproliferation observed in the<br/><i>Smed-PTEN</i></p>
<p style="position:absolute;top:525px;left:546px;white-space:nowrap" class="ft80">phenotype. Surprisingly, after rapamycin treatment,</p>
<p style="position:absolute;top:542px;left:468px;white-space:nowrap" class="ft89">the number of proliferative cells in triple RNAi worms was the same<br/>as in the control group (Student’s&#160;<i>t</i>-test,&#160;<i>P</i>&gt;0.4), although rapamycin<br/>treatment failed to prevent abnormal outgrowths (<i>n</i></p>
<p style="position:absolute;top:573px;left:767px;white-space:nowrap" class="ft80">=15/15, Fig. 6C</p>
<p style="position:absolute;top:593px;left:468px;white-space:nowrap" class="ft89">and supplementary material Fig. S4). Altogether these data suggest<br/>that, irrespective of proliferative levels, functional abrogation of<br/><i>Smed-PTEN</i></p>
<p style="position:absolute;top:627px;left:553px;white-space:nowrap" class="ft80">is sufficient to induce abnormal outgrowths.</p>
<p style="position:absolute;top:644px;left:468px;white-space:nowrap" class="ft810">Additionally, functional disruption of both&#160;<i>Smed-Akt&#160;</i>and&#160;&#160;<i>Smed-<br/>PTEN</i></p>
<p style="position:absolute;top:661px;left:511px;white-space:nowrap" class="ft80">genes reduce the capacity of rapamycin to prevent the</p>
<p style="position:absolute;top:678px;left:468px;white-space:nowrap" class="ft89">abnormalities observed in the&#160;<i>Smed-PTEN&#160;</i>phenotype, suggesting<br/>that to be fully effective, rapamycin treatment requires functional<br/><i>Akt</i></p>
<p style="position:absolute;top:712px;left:488px;white-space:nowrap" class="ft80">.</p>
<p style="position:absolute;top:747px;left:468px;white-space:nowrap" class="ft89"><b>DISCUSSION<br/></b>The analyses described here reveal details of the striking<br/>evolutionary conservation of PTEN function in stem cell regulation.<br/>Our data&#160;confirm that&#160;<i>S. mediterranea&#160;</i>offers unique opportunities<br/>to dissect, on a molecular basis, conserved, complex signaling<br/>pathways affecting adult somatic stem cells during homeostasis,<br/>disease, and uniquely, regeneration. Moreover, the&#160;<i>Smed-PTEN<br/></i>phenotype enables both the identification of factors controlling<br/>adult stem cells in tumor generation, and the opportunity to explore<br/>and test the mechanisms of action of therapeutic drugs that&#160;target<br/>elements of the PI3K-AKT-TOR pathway.</p>
<p style="position:absolute;top:951px;left:468px;white-space:nowrap" class="ft89"><b>Multiple PTEN forms exist in&#160;<i>S. mediterranea<br/></i></b>Phylogenic analysis of the three PTEN-like genes in planaria has<br/>lead to&#160;two interesting conclusions. Firstly,&#160;the analysis shows that<br/>planaria have undergone a paralogous duplication of the ancestral,<br/>single PTEN gene. The presence of two PTEN genes has not been<br/>described in any other invertebrate. Consistent with a relatively<br/>recent&#160;duplication, is the fact&#160;that&#160;both&#160;paralogs must be inactivated<br/>by RNAi to produce a phenotype. Secondly, expansion of the</p>
<p style="position:absolute;top:1100px;left:756px;white-space:nowrap" class="ft84"><b>dmm.biologists.org</b></p>
<p style="position:absolute;top:1100px;left:64px;white-space:nowrap" class="ft85"><b>138</b></p>
<p style="position:absolute;top:35px;left:670px;white-space:nowrap" class="ft86">PTEN regulates planarian adult stem cells</p>
<p style="position:absolute;top:28px;left:63px;white-space:nowrap" class="ft87"><b>RESEARCH ARTICLE</b></p>
<p style="position:absolute;top:728px;left:45px;white-space:nowrap" class="ft88"><i>D</i></p>
<p style="position:absolute;top:715px;left:45px;white-space:nowrap" class="ft88"><i>isease Models &amp; Mechanisms &#160; &#160; &#160; &#160;&#160;</i></p>
<p style="position:absolute;top:466px;left:45px;white-space:nowrap" class="ft88"><i>DMM</i></p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>eb7bcef887a877066e2c932dee6d95a6-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft90{font-size:12px;font-family:Times;color:#231f20;}
	.ft91{font-size:12px;font-family:Times;color:#231f20;}
	.ft92{font-size:11px;font-family:Times;color:#231f20;}
	.ft93{font-size:11px;font-family:Times;color:#231f20;}
	.ft94{font-size:7px;font-family:Times;color:#231f20;}
	.ft95{font-size:9px;font-family:Times;color:#261e5a;}
	.ft96{font-size:9px;font-family:Times;color:#231f20;}
	.ft97{font-size:9px;font-family:Times;color:#231f20;}
	.ft98{font-size:17px;font-family:Times;color:#261e5a;}
	.ft99{font-size:19px;font-family:Times;color:#261e5a;-moz-transform: matrix(         0,         -1,          1,          0, 0, 0);-webkit-transform: matrix(         0,         -1,          1,          0, 0, 0);-o-transform: matrix(         0,         -1,          1,          0, 0, 0);-ms-transform: matrix(         0,         -1,          1,          0, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft910{font-size:12px;line-height:17px;font-family:Times;color:#231f20;}
	.ft911{font-size:11px;line-height:17px;font-family:Times;color:#231f20;}
	.ft912{font-size:11px;line-height:16px;font-family:Times;color:#231f20;}
	.ft913{font-size:11px;line-height:17px;font-family:Times;color:#231f20;}
	.ft914{font-size:12px;line-height:17px;font-family:Times;color:#231f20;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page9-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:100px;left:64px;white-space:nowrap" class="ft910">vertebrate PTEN family into TPTE and TPIP was thought to be<br/>vertebrate-specific, because neither&#160;<i>C.&#160;elegans&#160;</i>nor Drosophila<br/>have a homolog to either of these genes. Surprisingly, planaria have<br/>a&#160;homolog&#160;that&#160;appears&#160;to&#160;be&#160;orthologous&#160;to&#160;both&#160;of&#160;these&#160;genes.<br/>These findings provide further evidence that&#160;<i>S. mediterranea&#160;</i>can<br/>be a useful invertebrate organism with&#160;which&#160;to functionally<br/>investigate questions involving genes that are present in vertebrates,<br/>but absent in Drosophila or&#160;<i>C.&#160;elegans</i>.</p>
<p style="position:absolute;top:254px;left:64px;white-space:nowrap" class="ft910"><i><b>S. mediterranea</b></i><b>: a model to study PTEN regulation of adult stem<br/>cells during tissue maintenance and regeneration<br/></b>Although PTEN and its substrate are evolutionarily conserved, the<br/>phenotypes, and endpoints from experimental assays may differ<br/>among biological model systems, owing to the ubiquity, complexity,<br/>and multiple effectors of the highly branched PI3K pathway (Stiles<br/>et&#160;al., 2004). This is particularly illustrated by studies on PTEN<br/>modulation of chemotaxis in Dictyostelium, signaling pathways in<br/>yeast,&#160;regulation of metabolic variables,&#160;longevity and dauer<br/>formation in&#160;<i>C. elegans,&#160;</i>and growth and size determination at the<br/>cellular and organ levels in Drosophila&#160;(Hafen, 2004; Stiles et al.,<br/>2004; Sulis and Parsons, 2003). Nonetheless, in mammals, recent<br/>attention has been drawn to the subtle roles that PTEN signaling<br/>plays in abnormal stem cell proliferation and its participation in<br/>carcinogenesis (Janzen and Scadden, 2006; Polyak and Hahn, 2006;<br/>Rossi and Weissman, 2006; Yilmaz et al., 2006; Zhang et al., 2006).</p>
<p style="position:absolute;top:526px;left:79px;white-space:nowrap" class="ft90">In&#160;&#160;<i>S. mediterranea</i>, the evolutionary conservation of signaling</p>
<p style="position:absolute;top:543px;left:64px;white-space:nowrap" class="ft910">pathways, the experimentally accessible adult stem cell population,<br/>and the robust regenerative capabilities of this organism provide a<br/>unique model with which to discover the mechanisms that control<br/>stem cells during homeostasis, tumorigenesis, and regeneration.<br/>Our data&#160;demonstrate&#160;that&#160;<i>S. mediterranea&#160;</i>provides a new<br/>invertebrate model system, in which the functions of different forms<br/>of PTEN can be abrogated in the entire adult animal, allowing for<br/>analysis of PTEN dysfunction in multiple organs, simultaneously<br/>– an experimental approach that is limited in mammalian models<br/>(Stiles et al., 2004; Sulis and Parsons, 2003). In addition,<br/>investigation of the possible roles of PTEN in the regeneration of<br/>complex structures is uniquely facilitated by the planarian model<br/>system. Understanding the in vivo function of PTEN in adult stem<br/>cell regulation is critical in order to design effective therapeutic<br/>strategies targeting components of the PI3K-Akt-TOR pathway.</p>
<p style="position:absolute;top:815px;left:64px;white-space:nowrap" class="ft914"><b>Analysis of the stem cells and their microenvironment during<br/>malignant transformation can be performed in the&#160;<i>Smed-PTEN<br/></i></b><b>phenotype<br/></b>Unlike other invertebrate models (Gao et al., 2000; Goberdhan et<br/>al., 1999; Hafen, 2004; Huang et al., 1999; Mihaylova et al., 1999;<br/>Ogg and Ruvkun, 1998), abrogation of PTEN function in adult&#160;<i>S.<br/>mediterranea</i></p>
<p style="position:absolute;top:917px;left:150px;white-space:nowrap" class="ft90">consistently led to visible outgrowths. A central</p>
<p style="position:absolute;top:934px;left:64px;white-space:nowrap" class="ft914">finding of our work is the overproliferation of neoblasts in animals<br/>in which both PTEN paralogs have been functionally abrogated.<br/>Because neoblasts are the only known dividing cells in planarians,<br/>and expression of both&#160;<i>Smed-PTEN-1&#160;</i>and&#160;<i>-2&#160;</i>were detected in these<br/>cells,&#160;it is reasonable to suggest that&#160;the observed hyperproliferation<br/>(Fig. 4G; Fig. 5C) may be due to autonomous cellular functions of<br/>PTEN in the planarian stem cells. Further, elimination of&#160;<i>Smed-<br/>Akt</i></p>
<p style="position:absolute;top:1053px;left:87px;white-space:nowrap" class="ft90">and addition of rapamycin in&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>animals</p>
<p style="position:absolute;top:1070px;left:64px;white-space:nowrap" class="ft90">did not prevent migration of the non-mitotic division progeny of</p>
<p style="position:absolute;top:100px;left:468px;white-space:nowrap" class="ft914">neoblasts; therefore, it is likely that&#160;other PTEN-regulated&#160;pathways<br/>may play a role in this particular aspect of the phenotype. One likely<br/>candidate is the integrin-mediated cell spreading and cell migration<br/>pathway, which is independent of mammalian TOR (mTOR) and<br/>is inhibited by PTEN (Gu et al., 1998). Hence, elimination of PTEN<br/>function in non-dividing planarian cells may enhance their<br/>migration and explain both tissue infiltration and the prevention<br/>of cephalic resorbption in rapamycin-treated&#160;<i>Smed-Akt(RNAi);<br/>Smed-PTEN-1, -2(RNAi)&#160;</i></p>
<p style="position:absolute;top:236px;left:627px;white-space:nowrap" class="ft90">animals.&#160;Further molecular analyses</p>
<p style="position:absolute;top:253px;left:468px;white-space:nowrap" class="ft90">should help to formally test this possibility.</p>
<p style="position:absolute;top:270px;left:483px;white-space:nowrap" class="ft90">We also observed a marked disruption of the basement</p>
<p style="position:absolute;top:287px;left:468px;white-space:nowrap" class="ft910">membrane, separating the epithelium from mesenchymal<br/>structures, which is accompanied by cellular infiltration and other<br/>morphological abnormalities (Fig. 4A-E). Interestingly, alterations<br/>of the epithelial-mesenchymal interactions, loss of tissue<br/>architecture, and the ensuing abnormal cell behaviors are<br/>considered to be both prerequisite and defining events in the<br/>progression of most cancers (Nelson and Bissell, 2006). In fact,<br/>anatomical alterations of epithelial-mesenchymal interactions<br/>represent a triggering signal in malignant transformation (Nelson<br/>and Bissell, 2006), as well as a proliferative response in neoblasts<br/>upon amputation (Hori, 1979b; Hori, 1980). Thus, we propose that<br/>the hyperproliferative response of neoblasts in the&#160;<i>Smed-PTEN<br/></i>phenotype may be additionally influenced by the disruption of<br/>anatomical barriers, and as such could be considered as a non-<br/>autonomous cellular&#160;effect of PTEN&#160;on neoblasts.</p>
<p style="position:absolute;top:542px;left:483px;white-space:nowrap" class="ft90">In the past, planarians have been used as in vivo models for</p>
<p style="position:absolute;top:559px;left:468px;white-space:nowrap" class="ft910">chemical-induced teratogenesis, and many of these studies led to<br/>the proposal that the hyperproliferative response of neoblasts to<br/>mutagenic compounds bears some resemblance to teratomas<br/>caused by embryonic stem cells, as well as benign and malignant<br/>tumors in mammals (Best and Morita, 1982; Foster, 1963; Foster,<br/>1969; Schaeffer, 1993). Interestingly, the observation that neoblast<br/>numbers increase after abrogation of PTEN function in planarians,<br/>is accompanied by a generalized infiltration of neoblast-like cells<br/>in many different organs, which supports this possibility. It is also<br/>consistent with previous findings, showing that embryonic stem<br/>cells (<i>PTEN–/–</i>) possess an enhanced capability to produce<br/>teratomas, after subcutaneous injections in syngeneic mice with<br/>similar histological features&#160;(i.e. increased cellularity, and dysplasia<br/>mostly composed of small, round undifferentiated cells) (Di<br/>Cristofano et al., 1998). Taken together, our findings strongly<br/>indicate that the&#160;<i>Smed-PTEN&#160;</i>phenotype provides a novel<br/>invertebrate context, in which the autonomous and non-<br/>autonomous regulation of tumor suppressors on adult stem cells<br/>can be simultaneously analyzed in all the different organs of a whole<br/>organism.</p>
<p style="position:absolute;top:917px;left:468px;white-space:nowrap" class="ft910"><b>Controlling abnormal stem cell proliferation by targeting<br/>components of the TOR pathway<br/></b>The PI3K-Akt-TOR pathway is evolutionarily conserved and it has<br/>been shown that loss of PTEN function activates Akt. Because<br/>functional abrogation of the&#160;<i>Smed-PTEN&#160;</i>genes led to&#160;increases in<br/><i>Smed-Akt</i></p>
<p style="position:absolute;top:1002px;left:531px;white-space:nowrap" class="ft90">expression, and because the symptoms of the&#160;<i>Smed-</i></p>
<p style="position:absolute;top:1019px;left:468px;white-space:nowrap" class="ft91"><i>PTEN</i></p>
<p style="position:absolute;top:1019px;left:514px;white-space:nowrap" class="ft90">phenotype were prevented by rapamycin treatment,</p>
<p style="position:absolute;top:1036px;left:468px;white-space:nowrap" class="ft914">components of this pathway are likely to be conserved in&#160;<i>S.<br/>mediterranea</i></p>
<p style="position:absolute;top:1053px;left:549px;white-space:nowrap" class="ft90">. The ability of rapamycin to&#160;regulate&#160;neoblast</p>
<p style="position:absolute;top:1070px;left:468px;white-space:nowrap" class="ft90">numbers, and their differentiation, during homeostasis and</p>
<p style="position:absolute;top:1100px;left:64px;white-space:nowrap" class="ft95"><b>Disease Models &amp; Mechanisms</b></p>
<p style="position:absolute;top:1100px;left:836px;white-space:nowrap" class="ft96"><b>139</b></p>
<p style="position:absolute;top:35px;left:64px;white-space:nowrap" class="ft97">PTEN regulates planarian adult stem cells</p>
<p style="position:absolute;top:28px;left:678px;white-space:nowrap" class="ft98"><b>RESEARCH ARTICLE</b></p>
<p style="position:absolute;top:728px;left:45px;white-space:nowrap" class="ft99"><i>D</i></p>
<p style="position:absolute;top:715px;left:45px;white-space:nowrap" class="ft99"><i>isease Models &amp; Mechanisms &#160; &#160; &#160; &#160;&#160;</i></p>
<p style="position:absolute;top:466px;left:45px;white-space:nowrap" class="ft99"><i>DMM</i></p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>eb7bcef887a877066e2c932dee6d95a6-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft100{font-size:12px;font-family:Times;color:#231f20;}
	.ft101{font-size:12px;font-family:Times;color:#231f20;}
	.ft102{font-size:11px;font-family:Times;color:#231f20;}
	.ft103{font-size:11px;font-family:Times;color:#231f20;}
	.ft104{font-size:11px;font-family:Times;color:#231f20;}
	.ft105{font-size:7px;font-family:Times;color:#231f20;}
	.ft106{font-size:9px;font-family:Times;color:#261e5a;}
	.ft107{font-size:9px;font-family:Times;color:#231f20;}
	.ft108{font-size:9px;font-family:Times;color:#231f20;}
	.ft109{font-size:17px;font-family:Times;color:#261e5a;}
	.ft1010{font-size:19px;font-family:Times;color:#261e5a;-moz-transform: matrix(         0,         -1,          1,          0, 0, 0);-webkit-transform: matrix(         0,         -1,          1,          0, 0, 0);-o-transform: matrix(         0,         -1,          1,          0, 0, 0);-ms-transform: matrix(         0,         -1,          1,          0, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft1011{font-size:12px;line-height:17px;font-family:Times;color:#231f20;}
	.ft1012{font-size:12px;line-height:17px;font-family:Times;color:#231f20;}
	.ft1013{font-size:11px;line-height:16px;font-family:Times;color:#231f20;}
	.ft1014{font-size:11px;line-height:17px;font-family:Times;color:#231f20;}
	.ft1015{font-size:11px;line-height:16px;font-family:Times;color:#231f20;}
	.ft1016{font-size:7px;line-height:17px;font-family:Times;color:#231f20;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page10-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:100px;left:64px;white-space:nowrap" class="ft1011">regeneration in the absence of functional&#160;<i>Smed-PTEN&#160;</i>genes,<br/>reveals a highly specific mechanism of action for rapamycin, and<br/>provides a unique opportunity to explore the mechanisms of<br/>action of this macrolide in vivo. Therefore, in planarians, it is<br/>possible to target abnormal proliferative cells while retaining an<br/>adequate neoblast response to&#160;meet&#160;physiological demands. This<br/>is consistent with&#160;recent&#160;findings demonstrating that&#160;rapamycin<br/>treatment compensates for PTEN loss, and is effective in preventing<br/>the development of leukemia-initiating cells, while maintaining<br/>normal hematopoietic function in mice (Yilmaz et al., 2006).<br/>However, the precise mechanism of action by which rapamycin<br/>distinguishes between abnormal and physiological stem cell<br/>proliferation is not completely understood and will require further<br/>analyses. Thus, the identification and characterization of additional,<br/>evolutionarily conserved components of the PI3K-Akt-TOR<br/>pathway, as well as possible targets of rapamycin, should be possible<br/>in planarians.</p>
<p style="position:absolute;top:389px;left:79px;white-space:nowrap" class="ft100">Even though an important consequence of abrogating&#160;<i>Smed-</i></p>
<p style="position:absolute;top:406px;left:64px;white-space:nowrap" class="ft101"><i>PTEN</i></p>
<p style="position:absolute;top:406px;left:103px;white-space:nowrap" class="ft100">genes was the generalized increase in&#160;<i>Smed-Akt&#160;</i>expression,</p>
<p style="position:absolute;top:423px;left:64px;white-space:nowrap" class="ft100">disruption of&#160;<i>Smed-Akt</i></p>
<p style="position:absolute;top:423px;left:239px;white-space:nowrap" class="ft100">function did not prevent the</p>
<p style="position:absolute;top:440px;left:64px;white-space:nowrap" class="ft1012">hyperproliferation and visible outgrowths that have been previously<br/>reported&#160;for this pathway in mammals (Chen et&#160;al., 2006). In fact,<br/>the only aspect of the&#160;<i>Smed-PTEN&#160;</i>loss-of-function phenotype<br/>rescued by abrogation of&#160;<i>Smed-Akt</i>, is the regression of the area in<br/>front of the photoreceptor – a region of the animal devoid of<br/>proliferative activity, and which is maintained exclusively by the<br/>migration of postmitotic neoblast progeny (Newmark and Sánchez<br/>Alvarado, 2000; Reddien et al., 2005b). Interestingly, the highest<br/>proportion of&#160;<i>Smed-Akt&#160;</i>expression in&#160;<i>Smed-PTEN-1, -2(RNAi)<br/></i>animals was observed in the X2 subpopulation of our FACS<br/>analyses, which includes migratory&#160;differentiating cells (Higuchi et<br/>al., 2007; Oviedo and Levin, 2007). Therefore, we propose that the<br/>abnormalities observed in the&#160;<i>Smed-PTEN&#160;</i>phenotype, such as head<br/>regression, may be&#160;associated with&#160;an abnormal increase&#160;in&#160;<i>Smed-<br/>Akt</i></p>
<p style="position:absolute;top:678px;left:91px;white-space:nowrap" class="ft100">expression, but others, such as hyperproliferation, lack of</p>
<p style="position:absolute;top:695px;left:64px;white-space:nowrap" class="ft1012">regeneration, and abnormal outgrowths are due specifically to the<br/>disruption of&#160;<i>Smed-PTEN&#160;</i>function. However, the partial<br/>preventative effect of rapamycin treatment in triple RNAi worms<br/>suggests that&#160;<i>Akt&#160;</i>is required&#160;to&#160;mediate rapamycin action in&#160;<i>Smed-<br/>PTEN(RNAi)&#160;</i></p>
<p style="position:absolute;top:763px;left:145px;white-space:nowrap" class="ft100">animals.</p>
<p style="position:absolute;top:798px;left:64px;white-space:nowrap" class="ft1011"><b>CONCLUSIONS<br/></b>Taken together, our findings provide insights into the evolution of<br/>PTEN, and the regulatory mechanism operating in adult stem cells<br/>during homeostasis and regeneration. Moreover, similar to<br/>mammalian adult stem cells,&#160;planarian neoblasts exists in a tightly<br/>regulated environment that&#160;allows constant&#160;support&#160;of<br/>differentiated tissues, while keeping the required form and function<br/>throughout the life of the organism (Newmark and Sánchez<br/>Alvarado, 2002; Reddien and Sánchez Alvarado, 2004; Sánchez<br/>Alvarado, 2006). Thus, the&#160;<i>Smed-PTEN&#160;</i>phenotype revealed that<br/>components of the neoblast regulatory&#160;mechanisms used&#160;during<br/>proliferation, differentiation and regeneration are conserved<br/>between planarians and mammals. As such, it is now possible to<br/>use&#160;<i>S. mediterranea&#160;</i>as a model, in which the pathways controlling<br/>adult stem cell biology and cellular regulation can be&#160;studied during<br/>the regeneration of complex structures. Equally important is the<br/>fact that abnormal stem cell proliferation can be specifically</p>
<p style="position:absolute;top:100px;left:468px;white-space:nowrap" class="ft1011">induced in&#160;<i>S. mediterranea</i>, broadening the opportunity to<br/>understand the relationship between cancer and stem cells. Future<br/>work will exploit the biology of&#160;<i>S. mediterranea&#160;</i>to pursue<br/>pharmacological, genetic and physiological approaches&#160;to&#160;elucidate<br/>potential therapeutic targets that could resolve PI3K-Akt-TOR<br/>pathway alterations.</p>
<p style="position:absolute;top:220px;left:468px;white-space:nowrap" class="ft1011"><b>METHODS<br/>Planarian culture<br/></b>The clonal asexual strain CIW4 of&#160;<i>Schmidtea mediterranea&#160;</i>was<br/>used in all experiments. Animals were kept and maintained as<br/>previously described (Cebrià and Newmark, 2005; Sánchez<br/>Alvarado et al., 2002).</p>
<p style="position:absolute;top:339px;left:468px;white-space:nowrap" class="ft1013"><i><b>Smed-PTEN&#160;</b></i><b>and&#160;<i>Smed-Akt&#160;</i></b><b>isolation<br/></b><i>PTEN</i></p>
<p style="position:absolute;top:356px;left:511px;white-space:nowrap" class="ft100">homologues&#160;&#160;<i>Smed-PTEN-1&#160;</i>and -<i>2&#160;</i>(accession numbers:</p>
<p style="position:absolute;top:373px;left:468px;white-space:nowrap" class="ft1011">AY068282 and AY066355, respectively) were identified in the<br/><i>Schmidtea mediterranea</i></p>
<p style="position:absolute;top:390px;left:617px;white-space:nowrap" class="ft100">database&#160;SmedDb (Sánchez Alvarado et</p>
<p style="position:absolute;top:407px;left:468px;white-space:nowrap" class="ft100">al., 2002). 5</p>
<p style="position:absolute;top:403px;left:536px;white-space:nowrap" class="ft100">⬘&#160;RACE&#160;was performed to&#160;isolate full lengths (Oviedo</p>
<p style="position:absolute;top:424px;left:468px;white-space:nowrap" class="ft1011">and Levin, 2007; Reddien et al., 2005b). Genomic sequences were<br/>obtained from the ongoing&#160;<i>S. mediterranea&#160;</i>Genome Project<br/>(Washington University Genome Sequence Center) to obtain<br/><i>Smed-Akt</i></p>
<p style="position:absolute;top:475px;left:530px;white-space:nowrap" class="ft100">and&#160;<i>Smed-PCNA&#160;</i>sequences.</p>
<p style="position:absolute;top:509px;left:468px;white-space:nowrap" class="ft1013"><b>Phylogenetic analysis<br/></b><i>PTEN</i></p>
<p style="position:absolute;top:526px;left:514px;white-space:nowrap" class="ft100">sequences were aligned with&#160;the program T-Coffee</p>
<p style="position:absolute;top:543px;left:468px;white-space:nowrap" class="ft1011">(Notredame et al., 2000). Alignments were edited by hand and<br/>subject&#160;to&#160;Bayesian analysis through the freeware&#160;program<br/>Geneious (www.geneious.com) and the MrBayes plugin (Ronquist<br/>and Huelsenbeck, 2003). MrBayes was run with parameters of<br/>1,000,000 generations, 4 chains, a subsample frequency of 500 and<br/>burnin of 100,000.</p>
<p style="position:absolute;top:662px;left:468px;white-space:nowrap" class="ft1016"><b>Gene expression studies<br/></b>Whole-mount ISHs<br/>Samples and probes for ISHs were processed as previously<br/>described (Oviedo and Levin, 2007; Reddien et al., 2005b). An<br/>optimized in situ&#160;protocol was also&#160;used&#160;for whole-mount analysis<br/>and is available upon request. Briefly, planaria are fixed with 4%<br/>formaldehyde in PBS, dehydrated and bleached in 6% H2O2<br/>overnight, treated with 3&#160;</p>
<p style="position:absolute;top:777px;left:634px;white-space:nowrap" class="ft100">μg/ml ProteinaseK for 10 minutes,</p>
<p style="position:absolute;top:798px;left:468px;white-space:nowrap" class="ft1011">postfixed in 4% formaldehyde for 10 minutes and then subject to<br/>previously described hybridization and detection. All images are<br/>representative of at least three different experiments and were<br/>captured as previously described (Oviedo and Levin, 2007; Oviedo<br/>et al., 2003).</p>
<p style="position:absolute;top:900px;left:468px;white-space:nowrap" class="ft1011">qRT-PCR<br/>Use of total RNA isolation procedures and internal controls were<br/>as previously described (Oviedo and Levin, 2007; Reddien et al.,<br/>2005b).</p>
<p style="position:absolute;top:985px;left:468px;white-space:nowrap" class="ft1015">ISH on dissociated cells and quantification of positive cells<br/>Planarian dissociation (<i>n</i></p>
<p style="position:absolute;top:998px;left:620px;white-space:nowrap" class="ft100">=10 per condition) was performed as</p>
<p style="position:absolute;top:1019px;left:468px;white-space:nowrap" class="ft1011">previously described (Oviedo and Levin, 2007; Reddien et al.,<br/>2005b) but without any filtration step. Briefly, dissociated cells were<br/>resuspended in equal volumes of calcium magnesium free&#160;media<br/>(CMF), spotted onto slides and fixed with 4% PFA. ISH was</p>
<p style="position:absolute;top:1100px;left:756px;white-space:nowrap" class="ft106"><b>dmm.biologists.org</b></p>
<p style="position:absolute;top:1100px;left:64px;white-space:nowrap" class="ft107"><b>140</b></p>
<p style="position:absolute;top:35px;left:670px;white-space:nowrap" class="ft108">PTEN regulates planarian adult stem cells</p>
<p style="position:absolute;top:28px;left:63px;white-space:nowrap" class="ft109"><b>RESEARCH ARTICLE</b></p>
<p style="position:absolute;top:728px;left:45px;white-space:nowrap" class="ft1010"><i>D</i></p>
<p style="position:absolute;top:715px;left:45px;white-space:nowrap" class="ft1010"><i>isease Models &amp; Mechanisms &#160; &#160; &#160; &#160;&#160;</i></p>
<p style="position:absolute;top:466px;left:45px;white-space:nowrap" class="ft1010"><i>DMM</i></p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>eb7bcef887a877066e2c932dee6d95a6-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft110{font-size:12px;font-family:Times;color:#231f20;}
	.ft111{font-size:11px;font-family:Times;color:#231f20;}
	.ft112{font-size:12px;font-family:Times;color:#231f20;}
	.ft113{font-size:9px;font-family:Times;color:#231f20;}
	.ft114{font-size:9px;font-family:Times;color:#231f20;}
	.ft115{font-size:9px;font-family:Times;color:#261e5a;}
	.ft116{font-size:17px;font-family:Times;color:#261e5a;}
	.ft117{font-size:10px;font-family:Times;color:#231f20;}
	.ft118{font-size:10px;font-family:Times;color:#231f20;}
	.ft119{font-size:19px;font-family:Times;color:#261e5a;-moz-transform: matrix(         0,         -1,          1,          0, 0, 0);-webkit-transform: matrix(         0,         -1,          1,          0, 0, 0);-o-transform: matrix(         0,         -1,          1,          0, 0, 0);-ms-transform: matrix(         0,         -1,          1,          0, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft1110{font-size:12px;line-height:17px;font-family:Times;color:#231f20;}
	.ft1111{font-size:11px;line-height:16px;font-family:Times;color:#231f20;}
	.ft1112{font-size:12px;line-height:17px;font-family:Times;color:#231f20;}
	.ft1113{font-size:9px;line-height:13px;font-family:Times;color:#231f20;}
	.ft1114{font-size:9px;line-height:13px;font-family:Times;color:#231f20;}
	.ft1115{font-size:10px;line-height:15px;font-family:Times;color:#231f20;}
	.ft1116{font-size:10px;line-height:15px;font-family:Times;color:#231f20;}
	.ft1117{font-size:10px;line-height:14px;font-family:Times;color:#231f20;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page11-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:100px;left:64px;white-space:nowrap" class="ft1110">performed as previously described (Oviedo and Levin, 2007;<br/>Reddien et al., 2005b). Nuclear counterstaining was performed with<br/>propidium iodide (PI). Cells that were positive for PI and different<br/>probes&#160;(neoblasts&#160;and differentiated tissues) were&#160;quantified with<br/>a compound scope (20</p>
<p style="position:absolute;top:165px;left:219px;white-space:nowrap" class="ft110">⫻&#160;objective) using IPLab software</p>
<p style="position:absolute;top:185px;left:64px;white-space:nowrap" class="ft1110">(Olympus). An average of total cell number was obtained from 20<br/>different fields per slide (neoblast markers), or, using a 20</p>
<p style="position:absolute;top:199px;left:438px;white-space:nowrap" class="ft110">⫻</p>
<p style="position:absolute;top:219px;left:64px;white-space:nowrap" class="ft1110">objective, the total number of positive cells per whole slide was<br/>recorded&#160;(differentiated tissue markers).</p>
<p style="position:absolute;top:271px;left:64px;white-space:nowrap" class="ft1110"><b>Planarian dissociation and FACS analyses<br/></b>Intact animals (<i>n</i>~10 per condition) were&#160;dissociated as&#160;previously<br/>described (Oviedo and Levin, 2007; Reddien et al., 2005b). Either<br/>FACSVantage (Becton Dickinson) or MoFlo high-speed cell sorter<br/>(Dako) were&#160;used&#160;to&#160;isolate cells.&#160;Results&#160;were&#160;analyzed&#160;by using<br/>CELL Quest (Becton Dickinson) or Summit (Dako) software<br/>(Oviedo and Levin, 2007; Reddien et al., 2005b).</p>
<p style="position:absolute;top:407px;left:64px;white-space:nowrap" class="ft1112"><b>dsRNA synthesis and microinjections<br/></b>dsRNA synthesis and microinjections were&#160;performed as<br/>previously described (Oviedo and Levin, 2007). Microinjection<br/>schedules were subjected to extensive rounds of optimization until<br/>reproducible results were obtained. Each injection was performed<br/>in the prepharyngeal area, consisting of three pulses of 32.2 nL<br/>each, at the time intervals depicted in Fig. 2A; Fig. 3A. Triple RNAi<br/>worms were injected&#160;on three consecutive days with&#160;dsRNA-<i>Smed-<br/>Akt</i></p>
<p style="position:absolute;top:543px;left:85px;white-space:nowrap" class="ft110">, followed by two days of rest, and then continued with the</p>
<p style="position:absolute;top:560px;left:64px;white-space:nowrap" class="ft1110">same schedule described for&#160;<i>Smed-PTEN-1, -2(RNAi)&#160;</i>worms.<br/>During the injection schedule, planarians were evaluated daily<br/>under the dissecting scope to observe behavioral reaction and<br/>external morphology. Signs of phenotypes were recorded when<br/>any of the following were first noticed: abnormal photophobic<br/>response, tip regression, external overgrowth, or epithelial damage.<br/>In most cases, the same number of animals for each condition<br/>(control, RNAi of an individual&#160;<i>Smed-PTEN&#160;</i>or simultaneous<br/><i>Smed-PTEN</i></p>
<p style="position:absolute;top:696px;left:139px;white-space:nowrap" class="ft110">-RNAi) were fixed or processed for additional</p>
<p style="position:absolute;top:713px;left:64px;white-space:nowrap" class="ft1110">experiments when 50% of the group displayed signs of the<br/>phenotype.</p>
<p style="position:absolute;top:764px;left:64px;white-space:nowrap" class="ft1110"><b>Rapamycin treatment<br/></b>Rapamycin was obtained from two sources: Calbiochem and Cell<br/>Signaling Technology. Concentrated stock was freshly diluted (20<br/>nM) in planarian water before daily prepharyngeal injections (five<br/>pulses&#160;of 32 nL each&#160;per worm). Rapamycin injections were&#160;always<br/>scheduled for 2-3 hours before respective dsRNA injections.</p>
<p style="position:absolute;top:883px;left:64px;white-space:nowrap" class="ft1110"><b>Antibody labeling and image collection<br/></b>Planarians were processed for immunostaining as previously<br/>described (Reddien et al., 2005a; Reddien et al., 2005b). Primary<br/>antibodies were&#160;diluted&#160;as follows:&#160;</p>
<p style="position:absolute;top:930px;left:273px;white-space:nowrap" class="ft110">α-phosphorylated histone H3</p>
<p style="position:absolute;top:951px;left:64px;white-space:nowrap" class="ft110">(Upstate), 1:5000;&#160;</p>
<p style="position:absolute;top:947px;left:168px;white-space:nowrap" class="ft110">α-arrestin (kind gift from K. Agata), 1:5000; anti-</p>
<p style="position:absolute;top:968px;left:64px;white-space:nowrap" class="ft1110">planarian myosin heavy chain monoclonal antibody TMUS-13<br/>(kind gift from R. Romero), 1:100;&#160;</p>
<p style="position:absolute;top:981px;left:260px;white-space:nowrap" class="ft110">α-acetylated tubulin monoclonal</p>
<p style="position:absolute;top:1002px;left:64px;white-space:nowrap" class="ft1110">antibody (Sigma), 1:500; and anti-SMEDWI-1 antibody (kind gift<br/>from P. Newmark), 1:1000. Incubation with secondary antibody was<br/>performed at room temperature, overnight in goat anti-rabbit Alexa<br/>568, 1:800, or goat anti-mouse Alexa 488, 1:400. At least seven or<br/>eight different whole body images were taken per condition to</p>
<p style="position:absolute;top:781px;left:468px;white-space:nowrap" class="ft1110">quantify the H3P signal as previously described (Reddien et al.,<br/>2005a; Reddien et al., 2005b). Representative images from each<br/>condition were additionally processed using an Olympus Fluoview-<br/>300 confocal microscope (Olympus), or as&#160;previously described<br/>(Oviedo and Levin, 2007).</p>
<p style="position:absolute;top:887px;left:468px;white-space:nowrap" class="ft1114"><b>ACKNOWLEDGEMENTS<br/></b>We thank P. Newmark, K. Agata and R. Romero for reagents; J. LaVecchio, B. Girijesh<br/>and the Harvard Stem Cell Institute Flow Cytometry Cores for FACS analysis; P.<br/>Reddien for sharing protocols, reagents and valuable suggestions; S. Morrison for<br/>rapamycin advice; J. Dobeck for histological assistance; R. Kent for assistance with<br/>data analysis; J. Jenkin, K. Gallant, D. Qiu and J. Morokuma for lab assistance; and C.-<br/>B. Chien and C. Rodesh for advice with imaging. N.J.O. is an NIH fellow supported<br/>under Ruth L. Kirschstein National Research Service Award (F32 GM078774). N.J.O.<br/>also thanks the Oviedo-Pfister family for encouragement. This work was supported<br/>by NSF grant IBN#0347295, NHTSA grant DTNH22-06-G-00001, and NIH grant R21<br/>HD055850 to M.L. and NIH-NIGMS RO-1 GM57260 to A.S.A. B.J.P. is a Damon<br/>Runyon Fellow (DRG#1888-05) and A.S.A. is a Howard Hughes Medical Institute<br/>Investigator. Part of this research was conducted in a Forsyth Institute facility<br/>renovated with support from Research Facilities Improvement Grant Number<br/>CO6RR11244 from the National Center for Research Resources, NIH.</p>
<p style="position:absolute;top:1100px;left:64px;white-space:nowrap" class="ft115"><b>Disease Models &amp; Mechanisms</b></p>
<p style="position:absolute;top:1100px;left:836px;white-space:nowrap" class="ft113"><b>141</b></p>
<p style="position:absolute;top:35px;left:64px;white-space:nowrap" class="ft114">PTEN regulates planarian adult stem cells</p>
<p style="position:absolute;top:28px;left:678px;white-space:nowrap" class="ft116"><b>RESEARCH ARTICLE</b></p>
<p style="position:absolute;top:101px;left:474px;white-space:nowrap" class="ft116"><b>TRANSLATIONAL IMPACT</b></p>
<p style="position:absolute;top:135px;left:474px;white-space:nowrap" class="ft1115"><b>Clinical issue<br/></b>Endogenous stem cells are important in the normal physiology of tissues that<br/>undergo constant regeneration, such as hematopoietic cells or those lining the<br/>gastrointestinal tract. The enhanced proliferative capacity of stem cells is<br/>necessary for the regeneration and healing of damaged tissue, but can also<br/>lead to cancer. The carcinogenic potential of stem cells is a significant<br/>limitation for their potential use in treating disease. Understanding the<br/>mechanisms and signaling pathways that allow stem cells to serve in a<br/>controlled regenerative capacity is necessary before their safe therapeutic<br/>potential can be realized.&#160;</p>
<p style="position:absolute;top:286px;left:486px;white-space:nowrap" class="ft117">The PTEN protein is a key regulator of cell proliferation, differentiation and</p>
<p style="position:absolute;top:301px;left:474px;white-space:nowrap" class="ft1115">motility that is frequently mutated in cancer. PTEN exerts its influence on<br/>cellular functions by suppressing the PI3-kinase (PI3K) and AKT pathways. In<br/>normal cells, PTEN balances PI3-kinase and AKT activities that otherwise would<br/>contribute to the genesis of malignant cancer cells.&#160;</p>
<p style="position:absolute;top:373px;left:474px;white-space:nowrap" class="ft1115"><b>Results<br/></b>Here the planarian is used as a model organism for studying PTEN in stem cells<br/>for tissue regeneration. Planarians contain large numbers of adult stem cells<br/>(neoblasts) that constantly renew and differentiate into all known planarian<br/>cell types.&#160;</p>
<p style="position:absolute;top:449px;left:486px;white-space:nowrap" class="ft117">In the planarian,&#160;<i>Schmidtea mediterranea</i>, the authors identify two</p>
<p style="position:absolute;top:464px;left:474px;white-space:nowrap" class="ft1115">orthologues to the human&#160;<i>PTEN&#160;</i>gene, which they name&#160;<i>Smed-PTEN-1&#160;</i>and<br/><i>Smed-PTEN-2</i>. They find the genes expressed in many cell types, including the<br/>planarian stem cells. Reduced expression of&#160;<i>Smed-PTEN-1&#160;</i>and&#160;<i>Smed-PTEN-2<br/></i>encoded proteins using RNAi resulted in abnormal growths, dramatic<br/>anatomical changes and the eventual demise of the organism. As in mammals,<br/>administration of the drug rapamycin to RNAi-treated worms prevents all of<br/>these abnormalities and the death of the animal.</p>
<p style="position:absolute;top:577px;left:474px;white-space:nowrap" class="ft1115"><b>Implications and future directions<br/></b>An important finding here is the extent of evolutionary conservation of the<br/>PTEN pathway that allows researchers to use planaria as a model organism for<br/>stem cell biology. This work demonstrates the fundamental importance of<br/>PTEN in cellular proliferation and differentiation processes. Work on the PTEN<br/>pathway in this system will advance our understanding of the mechanisms<br/>regulating proliferation, migration and motility that are likely operating in the<br/>emergence of human cancers. It also expands opportunities to understand the<br/>relationship between pathways that similarly regulate cancer growth and stem<br/>cell potential.</p>
<p style="position:absolute;top:736px;left:474px;white-space:nowrap" class="ft114">doi:10.1242/dmm.001123</p>
<p style="position:absolute;top:728px;left:45px;white-space:nowrap" class="ft119"><i>D</i></p>
<p style="position:absolute;top:715px;left:45px;white-space:nowrap" class="ft119"><i>isease Models &amp; Mechanisms &#160; &#160; &#160; &#160;&#160;</i></p>
<p style="position:absolute;top:466px;left:45px;white-space:nowrap" class="ft119"><i>DMM</i></p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>eb7bcef887a877066e2c932dee6d95a6-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft120{font-size:9px;font-family:Times;color:#231f20;}
	.ft121{font-size:9px;font-family:Times;color:#231f20;}
	.ft122{font-size:9px;font-family:Times;color:#231f20;}
	.ft123{font-size:9px;font-family:Times;color:#261e5a;}
	.ft124{font-size:17px;font-family:Times;color:#261e5a;}
	.ft125{font-size:19px;font-family:Times;color:#261e5a;-moz-transform: matrix(         0,         -1,          1,          0, 0, 0);-webkit-transform: matrix(         0,         -1,          1,          0, 0, 0);-o-transform: matrix(         0,         -1,          1,          0, 0, 0);-ms-transform: matrix(         0,         -1,          1,          0, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft126{font-size:9px;line-height:13px;font-family:Times;color:#231f20;}
	.ft127{font-size:9px;line-height:13px;font-family:Times;color:#231f20;}
	.ft128{font-size:9px;line-height:13px;font-family:Times;color:#231f20;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page12-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:101px;left:64px;white-space:nowrap" class="ft126"><b>COMPETING INTERESTS STATEMENT&#160;<br/></b>The authors declare no competing financial interests.</p>
<p style="position:absolute;top:136px;left:64px;white-space:nowrap" class="ft127"><b>AUTHOR CONTRIBUTIONS<br/></b>N.J.O. performed and analyzed all of the experiments with the exception of those<br/>reported in Fig. 1A-C, which were executed and interpreted by B.J.P. B.J.P. also<br/>optimized the whole-mount in situ hybridization protocol. A.S.A. and N.J.O.<br/>conceived the experiments. A.S.A. and M.L. supervised N.J.O. M.L. contributed<br/>reagents and participated in manuscript preparation. A.S.A., N.J.O. and B.J.P. wrote<br/>the manuscript.</p>
<p style="position:absolute;top:238px;left:64px;white-space:nowrap" class="ft127"><b>SUPPLEMENTARY MATERIAL<br/></b>Supplementary material for this article is available at<br/>http://dmm.biologists.org/content/suppl/2008/09/13/1.2-3.131.DC1</p>
<p style="position:absolute;top:287px;left:64px;white-space:nowrap" class="ft121">Received 9 January 2008; Accepted 29 March 2008.</p>
<p style="position:absolute;top:314px;left:64px;white-space:nowrap" class="ft126"><b>REFERENCES<br/>Asano, T., Yao, Y., Zhu, J., Li, D., Abbruzzese, J. L. and Reddy, S. A.&#160;</b>(2004).&#160;The PI 3-</p>
<p style="position:absolute;top:341px;left:74px;white-space:nowrap" class="ft127">kinase/Akt signaling pathway is activated due to aberrant Pten expression and<br/>targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells.<br/><i>Oncogene&#160;</i><b>23</b>, 8571-8580.</p>
<p style="position:absolute;top:381px;left:64px;white-space:nowrap" class="ft120"><b>Best, J. and Morita, M.&#160;</b>(1982).&#160;Planarians as a model system for in vitro teratogenesis</p>
<p style="position:absolute;top:394px;left:74px;white-space:nowrap" class="ft121">studies.&#160;<i>Teratog. Carcinog. Mutagen.&#160;</i><b>2</b>, 277-291.</p>
<p style="position:absolute;top:407px;left:64px;white-space:nowrap" class="ft120"><b>Cebrià, F. and Newmark, P. A.&#160;</b>(2005).&#160;Planarian homologs of netrin and netrin</p>
<p style="position:absolute;top:421px;left:74px;white-space:nowrap" class="ft127">receptor are required for proper regeneration of the central nervous system and the<br/>maintenance of nervous system architecture.&#160;<i>Development&#160;</i><b>132</b>, 3691-3703.</p>
<p style="position:absolute;top:447px;left:64px;white-space:nowrap" class="ft120"><b>Cebrià, F., Vispo, M., Bueno, D., Carranza, S., Newmark, P. and Romero, R.&#160;</b>(1996).</p>
<p style="position:absolute;top:461px;left:74px;white-space:nowrap" class="ft127">Myosin heavy chain gene in Dugesia (G.) tigrina: a tool for studying muscle<br/>regeneration in planarians.&#160;<i>Int. J. Dev. Biol.&#160;</i><b>Suppl.&#160;1</b>, 177S-178S.</p>
<p style="position:absolute;top:487px;left:64px;white-space:nowrap" class="ft120"><b>Chen, M. L., Xu, P. Z., Peng, X. D., Chen, W. S., Guzman, G., Yang, X., Di Cristofano,</b></p>
<p style="position:absolute;top:501px;left:74px;white-space:nowrap" class="ft127"><b>A., Pandolfi, P. P. and Hay, N.&#160;</b>(2006).&#160;The deficiency of Akt1 is sufficient to suppress<br/>tumor development in Pten+/- mice.&#160;<i>Genes Dev.&#160;</i><b>20</b>, 1569-1574.</p>
<p style="position:absolute;top:527px;left:64px;white-space:nowrap" class="ft120"><b>Clarke, M. F. and Fuller, M.&#160;</b>(2006).&#160;Stem cells and cancer: two faces of eve.&#160;<i>Cell&#160;</i><b>124</b>,</p>
<p style="position:absolute;top:541px;left:74px;white-space:nowrap" class="ft121">1111-1115.</p>
<p style="position:absolute;top:554px;left:64px;white-space:nowrap" class="ft120"><b>Di Cristofano, A., Pesce, B., Cordon-Cardo, C. and Pandolfi, P. P.&#160;</b>(1998).&#160;Pten is</p>
<p style="position:absolute;top:567px;left:74px;white-space:nowrap" class="ft127">essential for embryonic development and tumour suppression.&#160;<i>Nat. Genet.&#160;</i><b>19</b>, 348-<br/>355.</p>
<p style="position:absolute;top:594px;left:64px;white-space:nowrap" class="ft120"><b>Foster, J. A.&#160;</b>(1963).&#160;Induction of neoplasms in planarians with carcinogens.&#160;<i>Cancer Res.</i></p>
<p style="position:absolute;top:607px;left:74px;white-space:nowrap" class="ft120"><b>23</b>, 300-303.</p>
<p style="position:absolute;top:620px;left:64px;white-space:nowrap" class="ft120"><b>Foster, J. A.&#160;</b>(1969).&#160;Malformations and lethal growths in planaria treated with</p>
<p style="position:absolute;top:634px;left:74px;white-space:nowrap" class="ft121">carcinogens.&#160;<i>Natl. Cancer Inst. Monogr.&#160;</i><b>31</b>, 683-691.</p>
<p style="position:absolute;top:647px;left:64px;white-space:nowrap" class="ft120"><b>Gao, X., Neufeld, T. P. and Pan, D.&#160;</b>(2000).&#160;Drosophila PTEN regulates cell growth and</p>
<p style="position:absolute;top:660px;left:74px;white-space:nowrap" class="ft127">proliferation through PI3K-dependent and -independent pathways.&#160;<i>Dev. Biol.&#160;</i><b>221</b>,<br/>404-418.</p>
<p style="position:absolute;top:687px;left:64px;white-space:nowrap" class="ft120"><b>Gil, E. B., Malone Link, E., Liu, L. X., Johnson, C. D. and Lees, J. A.&#160;</b>(1999).&#160;Regulation</p>
<p style="position:absolute;top:700px;left:74px;white-space:nowrap" class="ft127">of the insulin-like developmental pathway of Caenorhabditis elegans by a homolog<br/>of the PTEN tumor suppressor gene.&#160;<i>Proc. Natl. Acad. Sci. USA&#160;</i><b>96</b>, 2925-2930.</p>
<p style="position:absolute;top:727px;left:64px;white-space:nowrap" class="ft120"><b>Goberdhan, D. C., Paricio, N., Goodman, E. C., Mlodzik, M. and Wilson, C.&#160;</b>(1999).</p>
<p style="position:absolute;top:740px;left:74px;white-space:nowrap" class="ft127">Drosophila tumor suppressor PTEN controls cell size and number by antagonizing<br/>the Chico/PI3-kinase signaling pathway.&#160;<i>Genes Dev.&#160;</i><b>13</b>, 3244-3258.</p>
<p style="position:absolute;top:767px;left:64px;white-space:nowrap" class="ft120"><b>Gu, J., Tamura, M. and Yamada, K. M.&#160;</b>(1998).&#160;Tumor Suppressor PTEN Inhibits</p>
<p style="position:absolute;top:780px;left:74px;white-space:nowrap" class="ft127">Integrin- and Growth Factor-mediated Mitogen-activated Protein (MAP) Kinase<br/>Signaling Pathways.&#160;<i>J. Cell Biol.&#160;</i><b>143</b>, 1375-1383.</p>
<p style="position:absolute;top:807px;left:64px;white-space:nowrap" class="ft120"><b>Guertin, D. A. and Sabatini, D. M.&#160;</b>(2007).&#160;Defining the Role of mTOR in Cancer.&#160;<i>Cancer</i></p>
<p style="position:absolute;top:820px;left:74px;white-space:nowrap" class="ft122"><i>Cell&#160;</i><b>12</b>, 9-22.</p>
<p style="position:absolute;top:834px;left:64px;white-space:nowrap" class="ft120"><b>Guo, T., Peters, A. H. and Newmark, P. A.&#160;</b>(2006).&#160;A bruno-like Gene Is Required for</p>
<p style="position:absolute;top:847px;left:74px;white-space:nowrap" class="ft121">Stem Cell Maintenance in Planarians.&#160;<i>Dev.&#160;Cell&#160;</i><b>11</b>, 159-169.</p>
<p style="position:absolute;top:860px;left:64px;white-space:nowrap" class="ft120"><b>Hafen, E.&#160;</b>(2004).&#160;Cancer, type 2 diabetes, and ageing: news from flies and worms.&#160;<i>Swiss</i></p>
<p style="position:absolute;top:874px;left:74px;white-space:nowrap" class="ft122"><i>Med. Wkly&#160;</i><b>134</b>, 711-719.</p>
<p style="position:absolute;top:887px;left:64px;white-space:nowrap" class="ft120"><b>Hayashi, T., Asami, M., Higuchi, S., Shibata, N. and Agata, K.&#160;</b>(2006).&#160;Isolation of</p>
<p style="position:absolute;top:900px;left:74px;white-space:nowrap" class="ft128">planarian X-ray-sensitive stem cells by fluorescence-activated cell sorting.&#160;<i>Dev.<br/>Growth Differ.&#160;</i><b>48</b>, 371-380.</p>
<p style="position:absolute;top:927px;left:64px;white-space:nowrap" class="ft120"><b>Higuchi, S., Hayashi, T., Hori, I., Shibata, N., Sakamoto, H. and Agata, K.&#160;</b>(2007).</p>
<p style="position:absolute;top:940px;left:74px;white-space:nowrap" class="ft127">Characterization and categorization of fluorescence activated cell sorted planarian<br/>stem cells by ultrastructural analysis.&#160;<i>Dev. Growth Differ.&#160;</i><b>49</b>, 571-581.</p>
<p style="position:absolute;top:967px;left:64px;white-space:nowrap" class="ft120"><b>Hori, I.&#160;</b>(1979a). Regeneration of the epidermis and basement membrane of the</p>
<p style="position:absolute;top:980px;left:74px;white-space:nowrap" class="ft121">planarian Dugesia japonica after total-body X irradiation.&#160;<i>Radiat. Res.&#160;</i><b>77</b>, 521-533.</p>
<p style="position:absolute;top:994px;left:64px;white-space:nowrap" class="ft120"><b>Hori, I.&#160;</b>(1979b). Structure and regeneration of the planarian basal lamina: an</p>
<p style="position:absolute;top:1007px;left:74px;white-space:nowrap" class="ft121">ultrastructural study.&#160;<i>Tissue Cell&#160;</i><b>11</b>, 611-621.</p>
<p style="position:absolute;top:1020px;left:64px;white-space:nowrap" class="ft120"><b>Hori, I.&#160;</b>(1980).&#160;Localization of newly synthesized precursors of basal lamina in the</p>
<p style="position:absolute;top:1034px;left:74px;white-space:nowrap" class="ft121">regenerating planarian as revealed by autoradiography.&#160;<i>Tissue Cell&#160;</i><b>12</b>, 513-521.</p>
<p style="position:absolute;top:1047px;left:64px;white-space:nowrap" class="ft120"><b>Huang, H., Potter, C. J., Tao, W., Li, D. M., Brogiolo, W., Hafen, E., Sun, H. and Xu, T.</b></p>
<p style="position:absolute;top:1060px;left:74px;white-space:nowrap" class="ft127">(1999).&#160;PTEN affects cell size, cell proliferation and apoptosis during Drosophila eye<br/>development.&#160;<i>Development&#160;</i><b>126</b>, 5365-5372.</p>
<p style="position:absolute;top:101px;left:468px;white-space:nowrap" class="ft120"><b>Janzen, V. and Scadden, D. T.&#160;</b>(2006).&#160;Stem cells: good, bad and reformable.&#160;<i>Nature</i></p>
<p style="position:absolute;top:115px;left:478px;white-space:nowrap" class="ft120"><b>441</b>, 418-419.</p>
<p style="position:absolute;top:128px;left:468px;white-space:nowrap" class="ft120"><b>Kirkegaard, T., Witton, C. J., McGlynn, L. M., Tovey, S. M., Dunne, B., Lyon, A. and</b></p>
<p style="position:absolute;top:142px;left:478px;white-space:nowrap" class="ft127"><b>Bartlett, J. M.&#160;</b>(2005).&#160;AKT activation predicts outcome in breast cancer patients<br/>treated with tamoxifen.&#160;<i>J Pathol&#160;</i><b>207</b>, 139-146.</p>
<p style="position:absolute;top:169px;left:468px;white-space:nowrap" class="ft120"><b>Lee, J. O., Yang, H., Georgescu, M. M., Di Cristofano, A., Maehama, T., Shi, Y.,</b></p>
<p style="position:absolute;top:182px;left:478px;white-space:nowrap" class="ft127"><b>Dixon, J. E., Pandolfi, P. and Pavletich, N. P.&#160;</b>(1999).&#160;Crystal structure of the PTEN<br/>tumor suppressor: implications for its phosphoinositide phosphatase activity and<br/>membrane association.&#160;<i>Cell&#160;</i><b>99</b>, 323-334.</p>
<p style="position:absolute;top:223px;left:468px;white-space:nowrap" class="ft120"><b>Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C.,</b></p>
<p style="position:absolute;top:236px;left:478px;white-space:nowrap" class="ft128"><b>Rodgers, L., McCombie, R. et al.&#160;</b>(1997).&#160;PTEN, a putative protein tyrosine<br/>phosphatase gene mutated in human brain, breast, and prostate cancer.&#160;<i>Science<br/></i><b>275</b>, 1943-1947.</p>
<p style="position:absolute;top:277px;left:468px;white-space:nowrap" class="ft120"><b>Liaw, D., Marsh, D. J., Li, J., Dahia, P. L., Wang, S. I., Zheng, Z., Bose, S., Call, K. M.,</b></p>
<p style="position:absolute;top:290px;left:478px;white-space:nowrap" class="ft127"><b>Tsou, H. C., Peacocke, M. et al.&#160;</b>(1997).&#160;Germline mutations of the PTEN gene in<br/>Cowden disease, an inherited breast and thyroid cancer syndrome.&#160;<i>Nat. Genet.&#160;</i><b>16</b>,<br/>64-67.</p>
<p style="position:absolute;top:331px;left:468px;white-space:nowrap" class="ft120"><b>Marsh, D. J., Dahia, P. L., Zheng, Z., Liaw, D., Parsons, R., Gorlin, R. J. and Eng, C.</b></p>
<p style="position:absolute;top:344px;left:478px;white-space:nowrap" class="ft128">(1997).&#160;Germline mutations in PTEN are present in Bannayan-Zonana syndrome.&#160;<i>Nat.<br/>Genet.&#160;</i><b>16</b>, 333-334.</p>
<p style="position:absolute;top:371px;left:468px;white-space:nowrap" class="ft120"><b>Marsh, D. J., Kum, J. B., Lunetta, K. L., Bennett, M. J., Gorlin, R. J., Ahmed, S. F.,</b></p>
<p style="position:absolute;top:385px;left:478px;white-space:nowrap" class="ft127"><b>Bodurtha, J., Crowe, C., Curtis, M. A., Dasouki, M. et al.&#160;</b>(1999).&#160;PTEN mutation<br/>spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba<br/>syndrome suggest a single entity with Cowden syndrome.&#160;<i>Hum. Mol. Genet.&#160;</i><b>8</b>, 1461-<br/>1472.</p>
<p style="position:absolute;top:439px;left:468px;white-space:nowrap" class="ft120"><b>Marx, J.&#160;</b>(2007).&#160;Molecular biology. Cancer’s perpetual source?&#160;<i>Science&#160;</i><b>317</b>, 1029-</p>
<p style="position:absolute;top:452px;left:478px;white-space:nowrap" class="ft121">1031.</p>
<p style="position:absolute;top:466px;left:468px;white-space:nowrap" class="ft120"><b>Mihaylova, V. T., Borland, C. Z., Manjarrez, L., Stern, M. J. and Sun, H.&#160;</b>(1999).&#160;The</p>
<p style="position:absolute;top:479px;left:478px;white-space:nowrap" class="ft128">PTEN tumor suppressor homolog in Caenorhabditis elegans regulates longevity and<br/>dauer formation in an insulin receptor-like signaling pathway.&#160;<i>Proc. Natl. Acad. Sci.<br/>USA&#160;</i><b>96</b>, 7427-7432.</p>
<p style="position:absolute;top:520px;left:468px;white-space:nowrap" class="ft120"><b>Nakahara, Y., Nagai, H., Kinoshita, T., Uchida, T., Hatano, S., Murate, T. and Saito,</b></p>
<p style="position:absolute;top:533px;left:478px;white-space:nowrap" class="ft127"><b>H.&#160;</b>(1998).&#160;Mutational analysis of the PTEN/MMAC1 gene in non-Hodgkin’s<br/>lymphoma.&#160;<i>Leukemia&#160;</i><b>12</b>, 1277-1280.</p>
<p style="position:absolute;top:560px;left:468px;white-space:nowrap" class="ft120"><b>Nelen, M. R., van Staveren, W. C., Peeters, E. A., Hassel, M. B., Gorlin, R. J., Hamm,</b></p>
<p style="position:absolute;top:574px;left:478px;white-space:nowrap" class="ft128"><b>H., Lindboe, C. F., Fryns, J. P., Sijmons, R. H., Woods, D. G. et al.&#160;</b>(1997).&#160;Germline<br/>mutations in the PTEN/MMAC1 gene in patients with Cowden disease.&#160;<i>Hum. Mol.<br/>Genet.&#160;</i><b>6</b>, 1383-1387.</p>
<p style="position:absolute;top:614px;left:468px;white-space:nowrap" class="ft120"><b>Nelson, C. M. and Bissell, M. J.&#160;</b>(2006).&#160;Of extracellular matrix, scaffolds, and signaling:</p>
<p style="position:absolute;top:628px;left:478px;white-space:nowrap" class="ft128">tissue architecture regulates development, homeostasis, and cancer.&#160;<i>Annu. Rev. Cell<br/>Dev. Biol.&#160;</i><b>22</b>, 287-309.</p>
<p style="position:absolute;top:655px;left:468px;white-space:nowrap" class="ft120"><b>Newmark, P. and Sánchez Alvarado, A.&#160;</b>(2000).&#160;Bromodeoxyuridine specifically labels</p>
<p style="position:absolute;top:668px;left:478px;white-space:nowrap" class="ft121">the regenerative stem cells of planarians.&#160;<i>Dev.&#160;Biol.&#160;</i><b>220</b>, 142-153.</p>
<p style="position:absolute;top:682px;left:468px;white-space:nowrap" class="ft120"><b>Newmark, P. A. and Sánchez Alvarado, A.&#160;</b>(2002).&#160;Not your father’s planarian: a classic</p>
<p style="position:absolute;top:695px;left:478px;white-space:nowrap" class="ft121">model enters the era of functional genomics.&#160;<i>Nat. Rev. Genet.&#160;</i><b>3</b>, 210-219.</p>
<p style="position:absolute;top:709px;left:468px;white-space:nowrap" class="ft120"><b>Notredame, C., Higgins, D. G. and Heringa, J.&#160;</b>(2000).&#160;T-Coffee: A novel method for</p>
<p style="position:absolute;top:722px;left:478px;white-space:nowrap" class="ft121">fast and accurate multiple sequence alignment.&#160;<i>J. Mol. Biol.&#160;</i><b>302</b>, 205-217.</p>
<p style="position:absolute;top:736px;left:468px;white-space:nowrap" class="ft120"><b>Ogg, S. and Ruvkun, G.&#160;</b>(1998).&#160;The C. elegans PTEN homolog, DAF-18, acts in the</p>
<p style="position:absolute;top:749px;left:478px;white-space:nowrap" class="ft121">insulin receptor-like metabolic signaling pathway.&#160;<i>Mol. Cell&#160;</i><b>2</b>, 887-893.</p>
<p style="position:absolute;top:763px;left:468px;white-space:nowrap" class="ft120"><b>Oldham, S., Stocker, H., Laffargue, M., Wittwer, F., Wymann, M. and Hafen, E.</b></p>
<p style="position:absolute;top:776px;left:478px;white-space:nowrap" class="ft127">(2002).&#160;The Drosophila insulin/IGF receptor controls growth and size by modulating<br/>PtdInsP(3) levels.&#160;<i>Development&#160;</i><b>129</b>, 4103-4109.</p>
<p style="position:absolute;top:803px;left:468px;white-space:nowrap" class="ft120"><b>Oviedo, N. J. and Levin, M.&#160;</b>(2007).&#160;smedinx-11 is a planarian stem cell gap junction</p>
<p style="position:absolute;top:817px;left:478px;white-space:nowrap" class="ft121">gene required for regeneration and homeostasis.&#160;<i>Development&#160;</i><b>134</b>, 3121-3131.</p>
<p style="position:absolute;top:830px;left:468px;white-space:nowrap" class="ft120"><b>Oviedo, N. J., Newmark, P. A. and Sánchez Alvarado, A.&#160;</b>(2003).&#160;Allometric scaling</p>
<p style="position:absolute;top:844px;left:478px;white-space:nowrap" class="ft128">and proportion regulation in the freshwater planarian Schmidtea mediterranea.&#160;<i>Dev.<br/>Dyn.&#160;</i><b>226</b>, 326-333.</p>
<p style="position:absolute;top:871px;left:468px;white-space:nowrap" class="ft120"><b>Polyak, K. and Hahn, W. C.&#160;</b>(2006).&#160;Roots and stems: stem cells in cancer.&#160;<i>Nat. Med.&#160;</i><b>12</b>,</p>
<p style="position:absolute;top:884px;left:478px;white-space:nowrap" class="ft121">296-300.</p>
<p style="position:absolute;top:898px;left:468px;white-space:nowrap" class="ft120"><b>Reddien, P. W., Bermange, A. L., Murfitt, K. J., Jennings, J. R. and Sánchez</b></p>
<p style="position:absolute;top:911px;left:478px;white-space:nowrap" class="ft128"><b>Alvarado,&#160;A.&#160;</b>(2005a). Identification of genes needed for regeneration, stem cell<br/>function, and tissue homeostasis by systematic gene perturbation in planaria.&#160;<i>Dev.<br/>Cell&#160;</i><b>8</b>, 635-649.</p>
<p style="position:absolute;top:952px;left:468px;white-space:nowrap" class="ft120"><b>Reddien, P. W., Oviedo, N. J., Jennings, J. R., Jenkin, J. C. and Sánchez Alvarado, A.</b></p>
<p style="position:absolute;top:965px;left:478px;white-space:nowrap" class="ft128">(2005b). SMEDWI-2 is a PIWI-like protein that regulates planarian stem cells.&#160;<i>Science<br/></i><b>310</b>, 1327-1330.</p>
<p style="position:absolute;top:992px;left:468px;white-space:nowrap" class="ft120"><b>Reddien, P. W. and Sánchez Alvarado, A.&#160;</b>(2004).&#160;Fundamentals of planarian</p>
<p style="position:absolute;top:1006px;left:478px;white-space:nowrap" class="ft121">regeneration.&#160;<i>Annu. Rev. Cell Dev. Biol.&#160;</i><b>20</b>, 725-757.</p>
<p style="position:absolute;top:1019px;left:468px;white-space:nowrap" class="ft120"><b>Reya, T. and Clevers, H.&#160;</b>(2005).&#160;Wnt signalling in stem cells and cancer.&#160;<i>Nature&#160;</i><b>434</b>,</p>
<p style="position:absolute;top:1033px;left:478px;white-space:nowrap" class="ft121">843-850.</p>
<p style="position:absolute;top:1046px;left:468px;white-space:nowrap" class="ft120"><b>Robb, S. M. and Sánchez Alvarado, A.&#160;</b>(2002).&#160;Identification of immunological</p>
<p style="position:absolute;top:1060px;left:478px;white-space:nowrap" class="ft127">reagents for use in the study of freshwater planarians by means of whole-mount<br/>immunofluorescence and confocal microscopy.&#160;<i>Genesis&#160;</i><b>32</b>, 293-298.</p>
<p style="position:absolute;top:1100px;left:756px;white-space:nowrap" class="ft123"><b>dmm.biologists.org</b></p>
<p style="position:absolute;top:1100px;left:64px;white-space:nowrap" class="ft120"><b>142</b></p>
<p style="position:absolute;top:35px;left:670px;white-space:nowrap" class="ft121">PTEN regulates planarian adult stem cells</p>
<p style="position:absolute;top:28px;left:63px;white-space:nowrap" class="ft124"><b>RESEARCH ARTICLE</b></p>
<p style="position:absolute;top:728px;left:45px;white-space:nowrap" class="ft125"><i>D</i></p>
<p style="position:absolute;top:715px;left:45px;white-space:nowrap" class="ft125"><i>isease Models &amp; Mechanisms &#160; &#160; &#160; &#160;&#160;</i></p>
<p style="position:absolute;top:466px;left:45px;white-space:nowrap" class="ft125"><i>DMM</i></p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>eb7bcef887a877066e2c932dee6d95a6-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft130{font-size:9px;font-family:Times;color:#231f20;}
	.ft131{font-size:9px;font-family:Times;color:#231f20;}
	.ft132{font-size:9px;font-family:Times;color:#231f20;}
	.ft133{font-size:9px;font-family:Times;color:#261e5a;}
	.ft134{font-size:17px;font-family:Times;color:#261e5a;}
	.ft135{font-size:19px;font-family:Times;color:#261e5a;-moz-transform: matrix(         0,         -1,          1,          0, 0, 0);-webkit-transform: matrix(         0,         -1,          1,          0, 0, 0);-o-transform: matrix(         0,         -1,          1,          0, 0, 0);-ms-transform: matrix(         0,         -1,          1,          0, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft136{font-size:9px;line-height:13px;font-family:Times;color:#231f20;}
	.ft137{font-size:9px;line-height:15px;font-family:Times;color:#231f20;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page13-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:101px;left:64px;white-space:nowrap" class="ft130"><b>Ronquist, F. and Huelsenbeck, J. P.&#160;</b>(2003).&#160;MrBayes&#160;<b>3</b>, Bayesian phylogenetic</p>
<p style="position:absolute;top:115px;left:74px;white-space:nowrap" class="ft131">inference under mixed models.&#160;<i>Bioinformatics&#160;</i><b>19</b>, 1572-1574.</p>
<p style="position:absolute;top:128px;left:64px;white-space:nowrap" class="ft130"><b>Rossi, D. J. and Weissman, I. L.&#160;</b>(2006).&#160;Pten, tumorigenesis, and stem cell self-renewal.</p>
<p style="position:absolute;top:142px;left:74px;white-space:nowrap" class="ft132"><i>Cell&#160;</i><b>125</b>, 229-231.</p>
<p style="position:absolute;top:155px;left:64px;white-space:nowrap" class="ft130"><b>Sabatini, D. M.&#160;</b>(2006).&#160;mTOR and cancer: insights into a complex relationship.&#160;<i>Nat. Rev.</i></p>
<p style="position:absolute;top:169px;left:74px;white-space:nowrap" class="ft132"><i>Cancer&#160;</i><b>6</b>, 729-734.</p>
<p style="position:absolute;top:182px;left:64px;white-space:nowrap" class="ft130"><b>Sakai, F., Agata, K., Orii, H. and Watanabe, K.&#160;</b>(2000).&#160;Organization and regeneration</p>
<p style="position:absolute;top:196px;left:74px;white-space:nowrap" class="ft136">ability of spontaneous supernumerary eyes in planarians -eye regeneration field and<br/>pathway selection by optic nerves-.&#160;<i>Zool. Sci.&#160;</i><b>17</b>, 375-381.</p>
<p style="position:absolute;top:222px;left:64px;white-space:nowrap" class="ft130"><b>Sánchez Alvarado, A.&#160;</b>(2006).&#160;Planarian regeneration: its end is its beginning.&#160;<i>Cell&#160;</i><b>124</b>,</p>
<p style="position:absolute;top:236px;left:74px;white-space:nowrap" class="ft131">241-245.</p>
<p style="position:absolute;top:249px;left:64px;white-space:nowrap" class="ft130"><b>Sánchez Alvarado, A. and Newmark, P. A.&#160;</b>(1999).&#160;Double-stranded RNA specifically</p>
<p style="position:absolute;top:263px;left:74px;white-space:nowrap" class="ft136">disrupts gene expression during planarian regeneration.&#160;<i>Proc. Natl. Acad. Sci. USA&#160;</i><b>96</b>,<br/>5049-5054.</p>
<p style="position:absolute;top:290px;left:64px;white-space:nowrap" class="ft130"><b>Sánchez Alvarado, A., Newmark, P. A., Robb, S. M. and Juste, R.&#160;</b>(2002).&#160;The</p>
<p style="position:absolute;top:303px;left:74px;white-space:nowrap" class="ft136">Schmidtea mediterranea database as a molecular resource for studying<br/>platyhelminthes, stem cells and regeneration.&#160;<i>Development&#160;</i><b>129</b>, 5659-5665.</p>
<p style="position:absolute;top:101px;left:468px;white-space:nowrap" class="ft130"><b>Sansal, I. and Sellers, W. R.&#160;</b>(2004).&#160;The biology and clinical relevance of the PTEN</p>
<p style="position:absolute;top:117px;left:478px;white-space:nowrap" class="ft131">tumor suppressor pathway.&#160;<i>J. Clin. Oncol.&#160;</i><b>22</b>, 2954-2963.</p>
<p style="position:absolute;top:132px;left:468px;white-space:nowrap" class="ft130"><b>Schaeffer, D. J.&#160;</b>(1993).&#160;Planarians as a model system for in vivo tumorigenesis studies.</p>
<p style="position:absolute;top:147px;left:478px;white-space:nowrap" class="ft132"><i>Ecotoxicol. Environ. Saf.&#160;</i><b>25</b>, 1-18.</p>
<p style="position:absolute;top:162px;left:468px;white-space:nowrap" class="ft130"><b>Stiles, B., Groszer, M., Wang, S., Jiao, J. and Wu, H.&#160;</b>(2004).&#160;PTENless means more.</p>
<p style="position:absolute;top:178px;left:478px;white-space:nowrap" class="ft132"><i>Dev. Biol.&#160;</i><b>273</b>, 175-184.</p>
<p style="position:absolute;top:193px;left:468px;white-space:nowrap" class="ft130"><b>Sulis, M. L. and Parsons, R.&#160;</b>(2003).&#160;PTEN: from pathology to biology.&#160;<i>Trends Cell Biol.</i></p>
<p style="position:absolute;top:208px;left:478px;white-space:nowrap" class="ft130"><b>13</b>, 478-483.</p>
<p style="position:absolute;top:224px;left:468px;white-space:nowrap" class="ft130"><b>Yilmaz, O. H., Valdez, R., Theisen, B. K., Guo, W., Ferguson, D. O., Wu, H. and</b></p>
<p style="position:absolute;top:239px;left:478px;white-space:nowrap" class="ft137"><b>Morrison, S. J.&#160;</b>(2006).&#160;Pten dependence distinguishes haematopoietic stem cells<br/>from leukaemia-initiating cells.&#160;<i>Nature&#160;</i><b>441</b>, 475-482.</p>
<p style="position:absolute;top:269px;left:468px;white-space:nowrap" class="ft130"><b>Zhang, J., Grindley, J. C., Yin, T., Jayasinghe, S., He, X. C., Ross, J. T., Haug, J. S.,</b></p>
<p style="position:absolute;top:285px;left:478px;white-space:nowrap" class="ft137"><b>Rupp, D., Porter-Westpfahl, K. S., Wiedemann, L. M. et al.&#160;</b>(2006).&#160;PTEN maintains<br/>haematopoietic stem cells and acts in lineage choice and leukaemia prevention.<br/><i>Nature&#160;</i><b>441</b>, 518-522.</p>
<p style="position:absolute;top:1100px;left:64px;white-space:nowrap" class="ft133"><b>Disease Models &amp; Mechanisms</b></p>
<p style="position:absolute;top:1100px;left:836px;white-space:nowrap" class="ft130"><b>143</b></p>
<p style="position:absolute;top:35px;left:64px;white-space:nowrap" class="ft131">PTEN regulates planarian adult stem cells</p>
<p style="position:absolute;top:28px;left:678px;white-space:nowrap" class="ft134"><b>RESEARCH ARTICLE</b></p>
<p style="position:absolute;top:728px;left:45px;white-space:nowrap" class="ft135"><i>D</i></p>
<p style="position:absolute;top:715px;left:45px;white-space:nowrap" class="ft135"><i>isease Models &amp; Mechanisms &#160; &#160; &#160; &#160;&#160;</i></p>
<p style="position:absolute;top:466px;left:45px;white-space:nowrap" class="ft135"><i>DMM</i></p>
</div>
</body>
</html>
